Download The Immune System: Innate and Adaptive Body Defenses

000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 766
21
PA R T 1
INNATE DEFENSES
Surface Barriers: Skin and Mucosae
(pp. 767–768)
Internal Defenses: Cells and
Chemicals (pp. 768–775)
PA R T 2
ADAPTIVE DEFENSES
Antigens (pp. 776–777)
Cells of the Adaptive Immune
System: An Overview
(pp. 777–780)
Humoral Immune Response
(pp. 780–786)
Cell-Mediated Immune Response
(pp. 786–795)
Homeostatic Imbalances of Immunity
(pp. 795–799)
Developmental Aspects of the
Immune System (p. 799)
766
The Immune
System: Innate
and Adaptive
Body Defenses
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 767
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
E
very second of every day, armies of hostile bacteria, fungi,
and viruses swarm on our skin and yet we stay amazingly
healthy most of the time. The body seems to have evolved
a single-minded approach to such foes—if you’re not with us,
you’re against us! To implement that stance, it relies heavily on
two intrinsic defense systems that act both independently and
cooperatively to provide resistance to disease, or immunity
(immun ⫽ free).
1. The innate (nonspecific) defense system, like a lowly foot
soldier, is always prepared, responding within minutes to
protect the body from all foreign substances. This system
has two “barricades.” The first line of defense is the external
body membranes—intact skin and mucosae. The second
line of defense, called into action whenever the first line has
been penetrated, uses antimicrobial proteins, phagocytes,
and other cells to inhibit the invaders’ spread throughout
the body. The hallmark of the second line of defense is inflammation.
2. The adaptive (or specific) defense system is more like an
elite fighting force equipped with high-tech weapons that
attacks particular foreign substances and provides the
body’s third line of defense. This defensive response takes
considerably more time to mount than the innate response.
Although we consider them separately, the adaptive and
innate systems always work hand in hand. An overview of
these two systems is shown in Figure 21.1. Small portions of
this diagram will reappear in subsequent figures to let you
know which part of the immune system we’re dealing with.
Although certain organs of the body (notably lymphoid organs) are intimately involved in the immune response, the
immune system is a functional system rather than an organ system in an anatomical sense. Its “structures” are a diverse array of
molecules plus trillions of immune cells (especially lymphocytes) that inhabit lymphoid tissues and circulate in body fluids.
Once, the term immune system was equated with the adaptive defense system only. However, we now know that the innate and adaptive defenses are deeply intertwined. Specifically,
(1) many defensive molecules are released and recognized by
both the innate and adaptive arms; (2) the innate responses are
not as nonspecific as once thought and have specific pathways
to target certain foreign substances; and (3) proteins released
during innate responses alert cells of the adaptive system to the
presence of specific foreign molecules in the body.
When the immune system is operating effectively, it protects
the body from most infectious microorganisms, cancer cells,
and transplanted organs or grafts. It does this both directly, by
cell attack, and indirectly, by releasing mobilizing chemicals and
protective antibody molecules.
PA R T
1
INNATE DEFENSES
Because they are part and parcel of our anatomy, you could say
we come fully equipped with innate defenses. The mechanical
barriers that cover body surfaces and the cells and chemicals
767
Surface barriers
• Skin
• Mucous membranes
Innate
defenses
Internal defenses
• Phagocytes
• NK cells
• Inflammation
• Antimicrobial proteins
• Fever
Humoral immunity
• B cells
Adaptive
defenses
Cellular immunity
• T cells
Figure 21.1 Overview of innate and adaptive defenses. Humoral immunity (primarily involving B lymphocytes) and cellular immunity (involving T lymphocytes) are distinct but overlapping areas
of adaptive immunity. For simplicity, the many interactions between
innate and adaptive defenses are not shown here.
that act on the initial internal battlefronts are in place at birth,
ready to ward off invading pathogens (harmful or diseasecausing microorganisms) and infection.
Many times, our innate defenses alone are able to destroy
pathogens and ward off infection. In other cases, the adaptive
immune system is called into action to reinforce and enhance
the innate defenses. Either way, the innate defenses reduce the
workload of the adaptive system by preventing the entry and
spread of microorganisms in the body.
Surface Barriers: Skin and Mucosae
䉴 Describe surface membrane barriers and their protective
functions.
The body’s first line of defense—the skin and the mucous membranes, along with the secretions these membranes produce—is
highly effective. As long as the epidermis is unbroken, this heavily
keratinized epithelial membrane presents a formidable physical barrier to most microorganisms that swarm on the skin.
Keratin is also resistant to most weak acids and bases and to
bacterial enzymes and toxins. Intact mucosae provide similar
mechanical barriers within the body. Recall that mucous
membranes line all body cavities that open to the exterior: the
digestive, respiratory, urinary, and reproductive tracts. Besides
serving as physical barriers, these epithelial membranes produce a variety of protective chemicals:
1. The acidity of skin secretions (pH 3 to 5) inhibits bacterial
growth. In addition, lipids in sebum and dermcidin in
21
000200010270575674_R1_CH21_p0766-0803.qxd
768
11/2/2011 02:45 PM Page 768
UN I T 4 Maintenance of the Body
eccrine sweat are toxic to bacteria. Vaginal secretions of
adult females are also very acidic.
2. The stomach mucosa secretes a concentrated hydrochloric
acid solution and protein-digesting enzymes. Both kill microorganisms.
3. Saliva, which cleanses the oral cavity and teeth, and
lacrimal fluid of the eye contain lysozyme, an enzyme that
destroys bacteria.
4. Sticky mucus traps many microorganisms that enter the
digestive and respiratory passageways.
The respiratory tract mucosae also have structural modifications that counteract potential invaders. Tiny mucus-coated
hairs inside the nose trap inhaled particles, and cilia on the mucosa of the upper respiratory tract sweep dust- and bacterialaden mucus toward the mouth, preventing it from entering the
lower respiratory passages, where the warm, moist environment
provides an ideal site for bacterial growth.
Although the surface barriers are quite effective, they are
breached occasionally by small nicks and cuts resulting, for example, from brushing your teeth or shaving. When this happens
and microorganisms invade deeper tissues, the internal innate
defenses come into play.
C H E C K Y O U R U N D E R S TA N D I N G
1. What distinguishes the innate defense system from the
adaptive defense system?
2. What is the first line of defense against disease?
For answers, see Appendix G.
Internal Defenses:
Cells and Chemicals
䉴 Explain the importance of phagocytosis and natural killer
cells in innate body defense.
21
The body uses an enormous number of nonspecific cellular and
chemical devices to protect itself, including phagocytes, natural
killer cells, antimicrobial proteins, and fever. The inflammatory
response enlists macrophages, mast cells, all types of white
blood cells, and dozens of chemicals that kill pathogens and
help repair tissue. All these protective ploys identify potentially
harmful substances by recognizing surface carbohydrates
unique to infectious organisms (bacteria, viruses, and fungi).
Phagocytes
Pathogens that get through the skin and mucosae into the underlying connective tissue are confronted by phagocytes (phago ⫽ eat).
The chief phagocytes are macrophages (“big eaters”), which
derive from white blood cells called monocytes that leave the
bloodstream, enter the tissues, and develop into macrophages.
Free macrophages, like the alveolar macrophages of the lungs,
wander throughout the tissue spaces in search of cellular debris
or “foreign invaders.” Fixed macrophages like Kupffer cells in the
liver and microglia of the brain are permanent residents of particular organs. Whatever their mobility, all macrophages are
similar structurally and functionally.
Neutrophils, the most abundant type of white blood cell,
become phagocytic on encountering infectious material in the
tissues.
Phagocytosis
A phagocyte engulfs particulate matter much the way an amoeba
ingests a food particle. Flowing cytoplasmic extensions bind to
the particle and then pull it inside, enclosed within a membranelined vesicle (Figure 21.2a). The resulting phagosome is then
fused with a lysosome to form a phagolysosome (steps 1 – 3 in
Figure 21.2b).
Phagocytic attempts are not always successful. In order for a
phagocyte to accomplish ingestion, adherence must occur. The
phagocyte must first adhere or cling to the pathogen, a feat
made possible by recognizing the pathogen’s carbohydrate “signature.” Recognition is particularly difficult with microorganisms such as pneumococcus, which have an external capsule
made of complex sugars. These pathogens can sometimes elude
capture because phagocytes cannot bind to their capsules. Adherence is both more probable and more efficient when complement proteins or antibodies coat foreign particles, a process
called opsonization (“to make tasty”), because the coating provides “handles” to which phagocyte receptors can bind.
Sometimes the way neutrophils and macrophages kill ingested prey is more than simple acidification and digestion by
lysosomal enzymes. For example, pathogens such as the tuberculosis bacillus and certain parasites are resistant to lysosomal
enzymes and can even multiply within the phagolysosome.
However, when the macrophage is stimulated by chemicals released by other immune cells called helper T cells, additional
enzymes are activated that produce the respiratory burst.
This event liberates a deluge of free radicals (including nitric
oxide and superoxide) that have potent cell-killing abilities.
More widespread cell killing is caused by oxidizing chemicals
(H2O2 and a substance identical to household bleach). The
respiratory burst also increases the pH and osmolarity in the
phagolysosome, which activates other protein-digesting
enzymes that digest the invader. Neutrophils also produce
antimicrobial chemicals, called defensins, that pierce the
pathogen’s membrane.
When phagocytes are unable to ingest their targets (because
of size, for example), they can release their toxic chemicals into
the extracellular fluid. Whether killing ingested or extracellular
targets, neutrophils rapidly destroy themselves in the process,
whereas macrophages are more robust and can go on to kill another day.
Natural Killer Cells
Natural killer (NK) cells, which “police” the body in blood and
lymph, are a unique group of defensive cells that can lyse and
kill cancer cells and virus-infected body cells before the adaptive
immune system is activated. Sometimes called the “pit bulls” of
the defense system, NK cells are part of a small group of large
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 769
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Innate defenses
769
1 Phagocyte adheres
to pathogens or debris.
Internal defenses
Phagosome
(phagocytic
vesicle)
Lysosome
Acid
hydrolase
enzymes
(a) A macrophage (purple) uses its cytoplasmic extensions
to pull spherical bacteria (green) toward it. Scanning
electron micrograph (1750ⴛ).
2 Phagocyte forms
pseudopods that
eventually engulf the
particles forming a
phagosome.
3 Lysosome fuses with
the phagocytic vesicle,
forming a phagolysosome.
4 Lysosomal enzymes
digest the particles,
leaving a residual body.
5 Exocytosis of the
vesicle removes
indigestible and
residual material.
(b) Events of phagocytosis.
Figure 21.2 Phagocytosis.
granular lymphocytes. Unlike lymphocytes of the adaptive immune system, which recognize and react only against specific
virus-infected or tumor cells, NK cells are far less picky. They
can eliminate a variety of infected or cancerous cells by detecting the lack of “self” cell-surface receptors and by recognizing
certain surface sugars on the target cell. The name “natural”
killer cells reflects this nonspecificity of NK cells.
NK cells are not phagocytic. Their mode of killing, which
involves direct contact and induces the target cell to undergo
apoptosis (programmed cell death), uses the same killing
mechanisms used by cytotoxic T cells (described fully on p. 792).
NK cells also secrete potent chemicals that enhance the inflammatory response.
Inflammation: Tissue Response to Injury
䉴 Describe the inflammatory process. Identify several inflammatory chemicals and indicate their specific roles.
The inflammatory response is triggered whenever body tissues
are injured by physical trauma (a blow), intense heat, irritating
chemicals, or infection by viruses, fungi, or bacteria. The inflammatory response has several beneficial effects:
1. Prevents the spread of damaging agents to nearby tissues
2. Disposes of cell debris and pathogens
3. Sets the stage for repair
The four cardinal signs of short-term, or acute, inflammation
are redness, heat (inflam ⫽ set on fire), swelling, and pain. If the
inflamed area is a joint, joint movement may be hampered temporarily. This forces the injured part to rest, which aids healing.
Some authorities consider impairment of function to be the fifth
cardinal sign of acute inflammation. Figure 21.3 presents an
overview of the inflammatory process, and shows how these
cardinal signs come about.
Vasodilation and Increased Vascular Permeability
The inflammatory process begins with a chemical “alarm” as a
flood of inflammatory chemicals are released into the extracellular fluid. Macrophages (and cells of certain boundary tissues
such as epithelial cells lining the gastrointestinal and respiratory
tracts) bear surface membrane receptors, called Toll-like
receptors (TLRs), that play a central role in triggering immune
responses. So far 11 types of human TLRs have been identified,
each recognizing a specific class of attacking microbe. For
example, one type responds to a glycolipid in cell walls of the
tuberculosis bacterium and another to a component of gramnegative bacteria such as Salmonella. Once activated, a TLR triggers the release of chemicals called cytokines that promote
inflammation and attract WBCs to the scene.
Macrophages are not the only sort of recognition “tool” in
the innate system. Mast cells, a key component of the inflammatory response, release the potent inflammatory chemical
histamine (his⬘tah-mēn). In addition, injured and stressed tissue cells, phagocytes, lymphocytes, basophils, and blood proteins are all sources of inflammatory mediators. These
chemicals include not only histamine and cytokines, but kinins
(ki⬘ninz), prostaglandins (pros⬙tah-glan⬘dinz), leukotrienes,
21
000200010270575674_R1_CH21_p0766-0803.qxd
770
11/2/2011 02:45 PM Page 770
UN I T 4 Maintenance of the Body
Innate defenses
Internal defenses
Initial stimulus
Physiological response
Signs of inflammation
Tissue injury
Result
Release of leukocytosisinducing factor
Release of chemical mediators
(histamine, complement,
kinins, prostaglandins, etc.)
Leukocytosis
(increased numbers of white
blood cells in bloodstream)
Vasodilation
of arterioles
Increased capillary
permeability
Local hyperemia
(increased blood
flow to area)
Capillaries
leak fluid
(exudate formation)
Leaked protein-rich
fluid in tissue spaces
Heat
21
Redness
Locally increased
temperature increases
metabolic rate of cells
Pain
Attract neutrophils,
monocytes, and
lymphocytes to
area (chemotaxis)
Margination
(leukocytes cling to
capillary walls)
Leaked clotting
proteins form interstitial
clots that wall off area
to prevent injury to
surrounding tissue
Diapedesis
(leukocytes pass through
capillary walls)
Phagocytosis of pathogens
and dead tissue cells
(by neutrophils, short-term;
by macrophages, long-term)
Swelling
Possible temporary
limitation of
joint movement
Leukocytes migrate to
injured area
Temporary fibrin
patch forms
scaffolding for repair
Pus may form
Area cleared of debris
Healing
Figure 21.3 Inflammation: flowchart of events. The four cardinal signs of acute
inflammation are shown in red boxes, as is limitation of joint movement, which in
some cases constitutes a fifth cardinal sign (impairment of function).
and complement. They all cause arterioles in the injured area to
dilate, although some of these mediators have individual inflammatory roles as well (Table 21.1). As more blood flows into
the area, local hyperemia (congestion with blood) occurs, accounting for the redness and heat of an inflamed region.
The liberated chemicals also increase the permeability of local
capillaries. Consequently, exudate—fluid containing clotting fac-
tors and antibodies—seeps from the blood into the tissue spaces.
This exudate causes the local swelling, also called edema, that
presses on adjacent nerve endings, contributing to a sensation of
pain. Pain also results from the release of bacterial toxins, and the
sensitizing effects of released prostaglandins and kinins. Aspirin
and some other anti-inflammatory drugs produce their analgesic
(pain-reducing) effects by inhibiting prostaglandin synthesis.
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 771
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Innate defenses
771
Internal defenses
Inflammatory
chemicals
diffusing from
the inflamed
site act as
chemotactic
agents.
4 Chemotaxis.
Neutrophils
follow chemical
trail.
Capillary wall
Basement
membrane
Endothelium
1 Leukocytosis.
Neutrophils enter
blood from bone
marrow.
2 Margination.
Neutrophils cling
to capillary wall.
3 Diapedesis.
Neutrophils flatten
and squeeze out of
capillaries.
Figure 21.4 Phagocyte mobilization.
Although edema may seem detrimental, it isn’t. The surge
of protein-rich fluids into the tissue spaces sweeps any foreign
material into the lymphatic vessels for processing in the
lymph nodes. It also delivers important proteins such as complement and clotting factors to the interstitial fluid (Figure
21.3). The clotting proteins form a gel-like fibrin mesh that
forms a scaffold for permanent repair. This isolates the injured area and prevents the spread of bacteria and other
harmful agents into surrounding tissues. Walling off the injured area is such an important defense strategy that some
bacteria (such as Streptococcus) have evolved enzymes that
break down the clot, allowing the bacteria to spread rapidly
into adjacent tissues.
At inflammatory sites where an epithelial barrier has been
breached, additional chemicals enter the battle—␤-defensins.
These broad-spectrum antimicrobial chemicals are continuously present in epithelial mucosal cells in small amounts and
help maintain the sterile environment of the body’s internal
passageways (urinary tract, respiratory bronchi, etc.). However,
when the mucosal surface is abraded or penetrated and the underlying connective tissue becomes inflamed, ␤-defensin output
increases dramatically, helping to control bacterial and fungal
colonization in the exposed area.
Phagocyte Mobilization
Soon after inflammation begins, the damaged area is flooded
with phagocytes. Neutrophils lead, followed by macrophages. If
the inflammation was provoked by pathogens, a group of
plasma proteins known as complement (to be discussed
shortly) is activated and elements of adaptive immunity (lymphocytes and antibodies) also migrate to the injured site. The
process by which phagocytes are mobilized to infiltrate the injured site consists of the four steps illustrated in Figure 21.4.
1
Leukocytosis. Neutrophils enter blood from red bone marrow in response to chemicals called leukocytosis-inducing
factors released by injured cells. Within a few hours, the
number of neutrophils in blood increases four- to fivefold,
resulting in leukocytosis (an increase in WBCs that is a
characteristic of inflammation).
2 Margination. Inflamed endothelial cells sprout cell adhesion molecules (CAMs) that signal “this is the place.” As
neutrophils encounter these CAMs, they slow and roll
along the surface, achieving an initial foothold. When activated by inflammatory chemicals, CAMs on neutrophils
bind tightly to endothelial cells. This clinging of phagocytes
to the inner walls of the capillaries and postcapillary
venules is called margination.
21
000200010270575674_R1_CH21_p0766-0803.qxd
772
11/2/2011 02:45 PM Page 772
UN I T 4 Maintenance of the Body
TABLE 21.1
Inflammatory Chemicals
CHEMICAL
SOURCE
PHYSIOLOGICAL EFFECTS
Histamine
Granules of mast cells and basophils. Released in response to mechanical injury, presence of certain microorganisms, and chemicals released by neutrophils.
Promotes vasodilation of local arterioles. Increases
permeability of local capillaries, promoting exudate
formation.
Kinins
(bradykinin and others)
A plasma protein, kininogen, is cleaved by the enzyme
kallikrein found in plasma, urine, saliva, and in lysosomes of neutrophils and other types of cells. Cleavage releases active kinin peptides.
Same as for histamine. Also induce chemotaxis of leukocytes and prompt neutrophils to release lysosomal
enzymes, thereby enhancing generation of more kinins. Induce pain.
Prostaglandins
Fatty acid molecules produced from arachidonic acid
found in all cell membranes; generated by enzymes
of neutrophils, basophils, mast cells, and others.
Same as for histamine. Also induce neutrophil chemotaxis. Induce pain.
Platelet-derived
growth factor (PDGF)
Secreted by platelets and endothelial cells.
Stimulates fibroblast activity and repair of damaged
tissues.
Complement
See Table 21.2 (below).
Cytokines
See Table 21.4 (p. 790).
TABLE 21.2
Summary of Innate Body Defenses
CATEGORY/ASSOCIATED
ELEMENTS
PROTECTIVE MECHANISM
First Line of Defense: Surface Membrane Barriers
Intact skin epidermis
Acid mantle
Skin secretions (sweat and sebum) make epidermal surface acidic, which inhibits bacterial growth; also contain
various bactericidal chemicals
■
Keratin
Provides resistance against acids, alkalis, and bacterial enzymes
Intact mucous membranes
21
Forms mechanical barrier that prevents entry of pathogens and other harmful substances into body
■
Form mechanical barrier that prevents entry of pathogens
■
Mucus
Traps microorganisms in respiratory and digestive tracts
■
Nasal hairs
Filter and trap microorganisms in nasal passages
■
Cilia
Propel debris-laden mucus away from nasal cavity and lower respiratory passages
■
Gastric juice
Contains concentrated hydrochloric acid and protein-digesting enzymes that destroy pathogens in stomach
■
Acid mantle of vagina
Inhibits growth of most bacteria and fungi in female reproductive tract
■
Lacrimal secretion
(tears); saliva
Continuously lubricate and cleanse eyes (tears) and oral cavity (saliva); contain lysozyme, an enzyme that destroys microorganisms
■
Urine
Normally acid pH inhibits bacterial growth; cleanses the lower urinary tract as it flushes from the body
Second Line of Defense: Innate Cellular and Chemical Defenses
Phagocytes
Engulf and destroy pathogens that breach surface membrane barriers; macrophages also contribute to adaptive immune responses
Natural killer (NK) cells
Promote apoptosis (cell suicide) by direct cell attack against virus-infected or cancerous body cells; do not require specific antigen recognition; do not exhibit a memory response
Inflammatory response
Prevents spread of injurious agents to adjacent tissues, disposes of pathogens and dead tissue cells, and promotes tissue repair; chemical mediators released attract phagocytes (and other immune cells) to the area
Antimicrobial proteins
■ Interferons (␣, ␤, ␥)
■
Complement
Fever
Proteins released by virus-infected cells and certain lymphocytes that protect uninfected tissue cells from viral
takeover; mobilize immune system
Lyses microorganisms, enhances phagocytosis by opsonization, and intensifies inflammatory and immune
responses
Systemic response initiated by pyrogens; high body temperature inhibits microbial multiplication and enhances body repair processes
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 773
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
3
Diapedesis. Continued chemical signaling prompts the
neutrophils to flatten and squeeze through the capillary
walls—diapedesis.
4 Chemotaxis. Inflammatory chemicals act as homing devices, or more precisely chemotactic agents. Neutrophils
and other WBCs migrate up the gradient of chemotactic
agents to the site of injury (positive chemotaxis). Within an
hour after the inflammatory response has begun, neutrophils have collected at the site and are devouring any foreign material present.
Innate defenses
Internal defenses
Virus
Viral nucleic acid
1 Virus
New
viruses
enters cell.
As the body’s counterattack continues, monocytes follow
neutrophils into the injured area. Monocytes are fairly poor
phagocytes, but within 12 hours of leaving the blood and
entering the tissues, they swell and develop large numbers of
lysosomes, becoming macrophages with insatiable appetites.
These late-arriving macrophages replace the neutrophils on the
battlefield.
Macrophages are the central actors in the final disposal of cell
debris as an acute inflammation subsides, and they predominate at sites of prolonged, or chronic, inflammation. The ultimate goal of an inflammatory response is to clear the injured
area of pathogens, dead tissue cells, and any other debris so that
tissue can be repaired. Once this is accomplished, healing usually occurs quickly.
Antimicrobial Proteins
䉴 Name the body’s antimicrobial substances and describe their
function.
A variety of antimicrobial proteins enhance the innate defenses by attacking microorganisms directly or by hindering
their ability to reproduce. The most important of these are interferons and complement proteins (Table 21.2).
5 Antiviral
proteins block viral
reproduction.
2 Interferon
genes switch on.
DNA
Nucleus
mRNA
4 Interferon
binding stimulates
cell to turn on
genes for antiviral
proteins.
H O M E O S TAT I C I M B A L A N C E
In severely infected areas, the battle takes a considerable toll
on both sides, and creamy yellow pus (a mixture of dead or
dying neutrophils, broken-down tissue cells, and living and
dead pathogens) may accumulate in the wound. If the inflammatory mechanism fails to clear the area of debris, the sac of
pus may be walled off by collagen fibers, forming an abscess.
Surgical drainage of abscesses is often necessary before healing can occur.
Some bacteria, such as tuberculosis bacilli, are resistant to digestion by the macrophages that engulf them. They escape the
effects of prescription antibiotics by remaining snugly enclosed
within their macrophage hosts. In such cases, infectious granulomas form. These tumorlike growths contain a central region of
infected macrophages surrounded by uninfected macrophages
and an outer fibrous capsule. A person may harbor pathogens
walled off in granulomas for years without displaying any
symptoms. However, if the person’s resistance to infection is
ever compromised, the bacteria may be activated and break out,
leading to clinical disease symptoms. ■
773
3 Cell produces
interferon
molecules.
Host cell 1
Infected by virus;
makes interferon;
is killed by virus
Interferon
Host cell 2
Binds interferon
from cell 1; interferon
induces synthesis of
protective proteins
Figure 21.5 The interferon mechanism against viruses.
Interferons
Viruses—essentially nucleic acids surrounded by a protein
coat—lack the cellular machinery to generate ATP or synthesize
proteins. They do their “dirty work,” or damage, in the body by
invading tissue cells and taking over the cellular metabolic machinery needed to reproduce themselves. The infected cells can
do little to save themselves, but some can secrete small proteins
called interferons (IFNs) (in⬙ter-fēr⬘onz) to help protect cells
that have not yet been infected. The IFNs diffuse to nearby cells,
where they stimulate synthesis of proteins which then “interfere” with viral replication in the still-healthy cells by blocking
protein synthesis and degrading viral RNA (Figure 21.5). Because IFN protection is not virus-specific, IFNs produced against
a particular virus protect against a variety of other viruses.
The IFNs are a family of related proteins produced by a variety of body cells, each having a slightly different physiological
effect. Lymphocytes secrete gamma (␥), or immune, interferon,
21
000200010270575674_R1_CH21_p0766-0803.qxd
774
11/2/2011 02:45 PM Page 774
UN I T 4 Maintenance of the Body
Classical pathway
Alternative pathway
Antigen-antibody complex
+
Spontaneous activation
+
Stabilizing factors (B, D, and P)
+
No inhibitors on pathogen surface
C1
C4
C2
complex
C3
C3a
C3b
C3b
C5b
MAC
Opsonization:
coats pathogen surfaces,
which enhances
phagocytosis
C5a
C6
C7
C8
Enhances inflammation:
stimulates histamine
release, increases
blood vessel permeability,
attracts phagocytes by
chemotaxis, etc.
C9
Insertion of MAC and cell lysis
(holes in target cell's membrane)
Pore
Complement
proteins
(C5b–C9)
Membrane
of target cell
21
Figure 21.6 Complement activation. In the classical pathway of complement activation,
antibodies coating the surface of a pathogen activate complement proteins C1, C4, and C2,
which in turn activate C3. In the alternative pathway of complement activation, C3 spontaneously
activates and attaches to pathogen membranes. (Unlike our own membranes, pathogen membranes
do not have inhibitors of complement activation.) Factors B, D, and P stabilize spontaneously
activated C3. The two pathways converge at C3, which splits into two active pieces: C3a and
C3b. C3a promotes inflammation (with the help of C5a). C3b enhances phagocytosis by acting
as an opsonin. In certain target cells (mostly bacteria), C3b also activates other complement
proteins that can form a membrane attack complex (MAC). MACs form from activated
complement components (C5b and C6 to C9) that insert into the target cell membrane, creating
funnel-shaped pores that can lyse the target cell.
but most other leukocytes secrete alpha (␣) interferon. Beta (␤)
interferon is secreted by fibroblasts. IFN-␤ and -␣ reduce inflammation, keeping it in control. Besides their antiviral effects,
interferons activate macrophages and mobilize NK cells.
Because both macrophages and NK cells can act directly against
malignant cells, the interferons play some anticancer role.
Genetically engineered IFNs have found a niche as antiviral
agents. For example, IFN-␣ is used to treat genital warts and
hepatitis C. IFN-␤ is used to treat patients with multiple sclerosis, a devastating demyelinating disease.
Complement
The term complement system, or simply complement, refers to
a group of at least 20 plasma proteins that normally circulate in
the blood in an inactive state. These proteins include C1
through C9, factors B, D, and P, plus several regulatory proteins.
Complement provides a major mechanism for destroying foreign substances in the body. Its activation unleashes chemical
mediators that amplify virtually all aspects of the inflammatory
process. Another effect of complement activation is that certain
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 775
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
bacteria and other cell types are killed by cell lysis. (Luckily our
own cells are equipped with proteins that inactivate complement.) Although complement is a nonspecific defensive mechanism, it “complements” (enhances) the effectiveness of both
innate and adaptive defenses.
Complement can be activated by the two pathways outlined
in Figure 21.6. The classical pathway involves antibodies, watersoluble protein molecules that the adaptive immune system
produces to fight off foreign invaders. The classical pathway
depends on the binding of antibodies to the invading organisms and the subsequent binding of C1 to the microorganismantibody complexes, a step called complement fixation, which
we will describe on p. 785. The alternative pathway is triggered
when spontaneously activated C3 and factors B, D, and P interact on the surface of certain microorganisms.
Like the blood clotting cascade, complement activation by
either pathway involves a cascade in which proteins are activated
in an orderly sequence—each step catalyzing the next. The two
pathways converge at C3, which cleaves into C3a and C3b. This
event initiates a common terminal pathway that enhances inflammation, promotes phagocytosis, and can cause cell lysis.
The lytic events begin when C3b binds to the target cell’s surface, triggering the insertion of a group of complement proteins
called MAC (membrane attack complex) into the cell’s membrane. MAC forms and stabilizes a hole in the membrane that
ensures lysis of the target cell by inducing a massive influx
of water.
The C3b molecules that coat the microorganism provide
“handles” that receptors on macrophages and neutrophils can
adhere to, allowing them to engulf the particle more rapidly. As
noted earlier, this process is called opsonization. C3a and other
cleavage products formed during complement fixation amplify
the inflammatory response by stimulating mast cells and basophils to release histamine and by attracting neutrophils and
other inflammatory cells to the area.
Fever
䉴 Explain how fever helps protect the body.
Inflammation is a localized response to infection, but sometimes
the body’s response to the invasion of microorganisms is more
widespread. Fever, or abnormally high body temperature, is a
systemic response to invading microorganisms. As we will describe further in Chapter 24, body temperature is regulated by a
cluster of neurons in the hypothalamus, commonly referred to as
the body’s thermostat. Normally set at approximately 37⬚C
(98.6⬚F), the thermostat is reset upward in response to chemicals
called pyrogens (pyro ⫽ fire), secreted by leukocytes and macrophages exposed to foreign substances in the body.
High fevers are dangerous because excess heat denatures enzymes. Mild or moderate fever, however, is an adaptive response
that seems to benefit the body. In order to multiply, bacteria require large amounts of iron and zinc, but during a fever the liver
and spleen sequester these nutrients, making them less available. Fever also increases the metabolic rate of tissue cells in
general, speeding up repair processes.
775
C H E C K Y O U R U N D E R S TA N D I N G
3. What is opsonization and how does it help phagocytes? Give
an example of a molecule that acts as an opsonin.
4. Under what circumstances are our own cells killed by NK cells?
5. What are the cardinal signs of inflammation and what causes
them?
For answers, see Appendix G.
PA R T
2
ADAPTIVE DEFENSES
Most of us would find it wonderfully convenient if we could walk
into a single clothing store and buy a complete wardrobe—hat to
shoes—that fit perfectly regardless of any special figure problems. We know that such a service would be next to impossible
to find. And yet, we take for granted our adaptive immune
system, the body’s built-in specific defensive system that stalks
and eliminates with nearly equal precision almost any type of
pathogen that intrudes into the body.
When it operates effectively, the adaptive immune system
protects us from a wide variety of infectious agents, as well as
from abnormal body cells. When it fails, or is disabled, the result
is such devastating diseases as cancer and AIDS. The activity of
the adaptive immune system tremendously amplifies the inflammatory response and is responsible for most complement
activation.
At first glance, the adaptive system seems to have a major
shortcoming. Unlike the innate system, which is always ready
and able to react, the adaptive system must “meet” or be primed
by an initial exposure to a specific foreign substance (antigen).
Only then can it protect the body against that substance, and
this priming takes precious time.
The basis of this specific immunity was revealed in the late
1800s. Researchers demonstrated that animals surviving a serious bacterial infection have in their blood protective factors
(the proteins we now call antibodies) that defend against future
attacks by the same pathogen. Furthermore, researchers found
that if antibody-containing serum from the surviving animals
was injected into animals that had not been exposed to the
pathogen, those injected animals would also be protected.
These landmark experiments were exciting because they
revealed three important aspects of the adaptive immune
response:
1. It is specific. It recognizes and is directed against particular
pathogens or foreign substances that initiate the immune
response.
2. It is systemic. Immunity is not restricted to the initial infection site.
3. It has “memory.” After an initial exposure, it recognizes
and mounts even stronger attacks on the previously encountered pathogens.
21
000200010270575674_R1_CH21_p0766-0803.qxd
776
11/2/2011 02:45 PM Page 776
UN I T 4 Maintenance of the Body
Antigenbinding
sites
Antibody A
Antigenic determinants
Antigen
Antibody B
Antibody C
Figure 21.7 Most antigens have several different antigenic
determinants. Antibodies (and related receptors on lymphocytes)
bind to small areas on the antigen surface called antigenic
determinants. In this example, three types of antibodies react with
different antigenic determinants on the same antigen molecule.
21
At first antibodies were thought to be the sole artillery of the
adaptive immune system, but in the mid-1900s it was discovered
that injection of antibody-containing serum did not always protect the recipient from diseases the serum donor had survived.
In such cases, however, injection of the donor’s lymphocytes did
provide immunity. As the pieces fell into place, researchers recognized two separate but overlapping arms of adaptive immunity, each using a variety of attack mechanisms that vary with
the intruder.
Humoral immunity (hu⬘mor-ul), also called antibodymediated immunity, is provided by antibodies present in the
body’s “humors,” or fluids (blood, lymph, etc.). Though they are
produced by lymphocytes (or their offspring), antibodies circulate freely in the blood and lymph, where they bind primarily to
bacteria, to bacterial toxins, and to free viruses, inactivating
them temporarily and marking them for destruction by phagocytes or complement.
When lymphocytes themselves rather than antibodies defend the body, the immunity is called cellular or cell-mediated
immunity because the protective factor is living cells. Cellular
immunity also has cellular targets—virus-infected or parasiteinfected tissue cells, cancer cells, and cells of foreign grafts. The
lymphocytes act against such targets either directly, by killing
the foreign cells, or indirectly, by releasing chemical mediators
that enhance the inflammatory response or activate other lymphocytes or macrophages. As you can see, both arms of the
adaptive immune system respond to virtually the same foreign
substances, but they do it in very different ways.
Before we describe the humoral and cell-mediated responses, let’s first consider the antigens that trigger the activity
of the remarkable cells involved in these immune responses.
Antigens
䉴 Define antigen and describe how antigens affect the adaptive defenses.
䉴 Define complete antigen, hapten, and antigenic determinant.
Antigens (an⬘tı̆-jenz) are substances that can mobilize the
adaptive defenses and provoke an immune response. They are
the ultimate targets of all adaptive immune responses. Most
antigens are large, complex molecules (both natural and synthetic) that are not normally present in the body. Consequently,
as far as our immune system is concerned, they are intruders, or
nonself.
Complete Antigens and Haptens
Antigens can be complete or incomplete. Complete antigens
have two important functional properties:
1. Immunogenicity, which is the ability to stimulate proliferation of specific lymphocytes and antibodies. (Antigen is
a contraction of “antibody generating,” which refers to this
particular antigenic property.)
2. Reactivity, which is the ability to react with the activated
lymphocytes and the antibodies released by immunogenic
reactions.
An almost limitless variety of foreign molecules can act as
complete antigens, including virtually all foreign proteins, many
large polysaccharides, and some lipids and nucleic acids. Of
these, proteins are the strongest antigens. Pollen grains and
microorganisms—such as bacteria, fungi, and virus particles—
are all immunogenic because their surfaces bear many different
foreign macromolecules.
As a rule, small molecules—such as peptides, nucleotides,
and many hormones—are not immunogenic. But, if they link
up with the body’s own proteins, the adaptive immune system
may recognize the combination as foreign and mount an attack
that is harmful rather than protective. (We describe these reactions, called hypersensitivities, later in the chapter.) In such
cases, the troublesome small molecule is called a hapten
(hap⬘ten; haptein ⫽ grasp) or incomplete antigen. Unless attached to protein carriers, haptens have reactivity but not immunogenicity. Besides certain drugs (particularly penicillin),
chemicals that act as haptens are found in poison ivy, animal
dander, detergents, cosmetics, and a number of common
household and industrial products.
Antigenic Determinants
The ability of a molecule to act as an antigen depends on both
its size and its complexity. Only certain parts of an entire antigen, called antigenic determinants, are immunogenic. Free antibodies or lymphocyte receptors bind to these sites in much the
same manner an enzyme binds to a substrate.
Most naturally occurring antigens have a variety of antigenic
determinants on their surfaces, some more potent than others
in provoking an immune response (Figure 21.7). Different antigenic determinants are “recognized” by different lymphocytes,
so a single antigen may mobilize several lymphocyte populations and may stimulate formation of many kinds of antibodies.
Large proteins have hundreds of chemically different antigenic
determinants, which accounts for their high immunogenicity
and reactivity. However, large simple molecules such as plastics,
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 777
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
777
which have many identical, regularly repeating units (and so are
not chemically complex), have little or no immunogenicity.
Such substances are used to make artificial implants because the
substances are not seen as foreign and rejected by the body.
nity. T lymphocytes or T cells are non-antibody-producing
lymphocytes that constitute the cell-mediated arm of adaptive
immunity. Unlike the lymphocytes, APCs do not respond to
specific antigens but instead play essential auxiliary roles.
Self-Antigens: MHC Proteins
Lymphocytes
The external surfaces of all our cells are dotted with a huge variety of protein molecules. Assuming your immune system has
been properly “programmed,” your self-antigens are not foreign or antigenic to you, but they are strongly antigenic to other
individuals. (This is the basis of transfusion reactions and graft
rejection.)
Among the cell surface proteins that mark a cell as self is a
group of glycoproteins called MHC proteins. Genes of the
major histocompatibility complex (MHC) code for these proteins. Because millions of combinations of these genes are possible, it is unlikely that any two people except identical twins
have the same MHC proteins.
There are two major groups of MHC proteins, distinguished
by location. Class I MHC proteins are found on virtually all
body cells, but class II MHC proteins are found only on certain
cells that act in the immune response.
Each MHC molecule has a deep groove that typically displays
a peptide. In healthy cells, peptides displayed by class I MHC
come from the breakdown of cellular proteins during normal
protein recycling and tend to be quite diverse, but are nevertheless all self-antigens. However, in infected cells, class I MHC also
binds fragments of foreign antigens that come from within the
infected cell. Peptides displayed by class II MHC come from outside the cell. As we will describe shortly, these displayed peptides
play a crucial role in mobilizing the adaptive defenses.
Like all other blood cells, lymphocytes originate in red bone
marrow from hematopoietic stem cells. During development,
lymphocytes are “educated.”The aim of this education is twofold:
C H E C K Y O U R U N D E R S TA N D I N G
Development of Immunocompetence
and Self-Tolerance
6. Name three key characteristics of adaptive immunity.
7. What is the difference between a complete antigen and a
hapten?
8. What marks a cell as “self” as opposed to “nonself”?
For answers, see Appendix G.
Cells of the Adaptive Immune
System: An Overview
䉴 Compare and contrast the origin, maturation process, and
general function of B and T lymphocytes.
䉴 Define immunocompetence and self-tolerance, and describe
their development in B and T lymphocytes.
䉴 Name several antigen-presenting cells and describe their
roles in adaptive defenses.
The three crucial cell types of the adaptive immune system are
two distinct populations of lymphocytes, plus antigen-presenting
cells (APCs). B lymphocytes or B cells oversee humoral immu-
1. Immunocompetence. Each lymphocyte must become able
(competent) to recognize its one specific antigen by binding to it. This ability is called immunocompetence.
2. Self-tolerance. Each lymphocyte must be relatively unresponsive to self-antigens so that it does not attack the
body’s own cells. This is called self-tolerance.
B and T cells are educated in different parts of the body.
T cells undergo this two- to three-day maturation process in the
thymus. B cells become immunocompetent and self-tolerant in
the bone marrow. The lymphoid organs where the lymphocytes
become immunocompetent—thymus and bone marrow—are
called primary lymphoid organs. All other lymphoid organs
are referred to as secondary lymphoid organs.
Immunocompetent B and T cells that have not yet been exposed to antigen are called naive. Naive B cells and T cells are exported to the lymph nodes, spleen, and other secondary
lymphoid organs, where encounters with antigens may occur.
Then, when the lymphocytes bind with recognized antigens, the
lymphocytes are activated to complete their differentiation into
effector and memory B or T cells. Figure 21.8 summarizes lymphocyte development.
When B or T cells become immunocompetent, they display a
unique type of receptor on their surface. These receptors (some
105 per cell) enable the lymphocyte to recognize and bind a specific antigen. Once these receptors appear, the lymphocyte is
committed to react to one distinct antigenic determinant, and
one only, because all of its antigen receptors are the same.
The receptors on B cells are in fact membrane-bound antibodies, while the receptors on T cells are not antibodies but are
products of the same gene superfamily. These similar structures
have similar functions, and both cell types are capable of responding to the same antigens.
For T cells, the education in the thymus ensures that they
meet two essential criteria for life as a successful T cell. First, the
T cell must be able to bind MHC molecules, since it is on these
molecules that antigens are presented to the T cell for recognition. Second, the T cell must not react strongly to self-antigens
that are normally found in the body.
In order to ensure that all T cells meet these criteria, their education consists of positive and negative selection (Figure 21.9).
Positive selection, which occurs in the thymic cortex, is essentially an MHC restriction process. It identifies T cells whose
21
000200010270575674_R1_CH21_p0766-0803.qxd
778
11/2/2011 02:45 PM Page 778
UN I T 4 Maintenance of the Body
Adaptive defenses
Red bone marrow: site of lymphocyte origin
Humoral immunity
Cellular immunity
Primary lymphoid organs: site of
development of immunocompetence as B or
T cells
Secondary lymphoid organs: site of
antigen encounter, and activation to become
effector and memory B or T cells
Red bone marrow
Immature
lymphocytes
Thymus
1 Lymphocytes destined to become T cells
migrate (in blood) to the thymus and develop
immunocompetence there. B cells develop
immunocompetence in red bone marrow.
Bone marrow
Lymph nodes, spleen,
and other lymphoid
tissues
2 Immunocompetent but still naive lymphocytes
leave the thymus and bone marrow. They “seed”
the lymph nodes, spleen, and other lymphoid tissues
where they encounter their antigen.
3 Antigen-activated immunocompetent
lymphocytes (effector cells and memory cells)
circulate continuously in the bloodstream and lymph
and throughout the lymphoid organs of the body.
21
Figure 21.8 Lymphocyte traffic. Immature lymphocytes arise in red bone marrow. (Note that
red marrow is not found in the medullary cavity of the diaphysis of long bones in adults.) Plasma
cells (antibody-secreting effector B cells) usually do not circulate.
receptors are capable of recognizing (binding) self-MHC molecules and eliminates all others. In this way positive selection
produces an army of self-MHC-restricted T cells.
T cells that make it through positive selection are then
tested to make sure that they do not recognize (bind tightly)
self-antigens displayed on self-MHC. If they do, they are eliminated by apoptosis (programmed cell death). This is negative
selection, and it occurs in the inner edge of the thymic cortex.
Negative selection ensures immunologic self-tolerance, making sure that T cells don’t attack the body’s own cells, which
would cause autoimmune disorders. This education of T cells
is expensive indeed—only about 2% of T cells survive it and
continue on to become successful immunocompetent, selftolerant T cells.
Less is known about the factors that control B cell maturation in humans. In the bone marrow, self-reactive B cells are
either eliminated by apoptosis (clonal deletion), or are given a
chance to change their self-reactive antigen receptor by receptor
editing, in which there is another rearrangement of the antigenbinding part of the receptor. Nevertheless, some self-reacting
B cells do leave the bone marrow. In the periphery, these selfreactive B cells are inactivated (a phenomenon called anergy).
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 779
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Generation of Antigen Receptor
Diversity in Lymphocytes
We know that lymphocytes become immunocompetent before
meeting the antigens they may later attack. It is our genes, not antigens, that determine what specific foreign substances our immune
system will be able to recognize and resist. In other words, the immune cell receptors represent our genetically acquired knowledge of the microbes that are likely to be in our environment.
An antigen simply determines which existing T or B cells will
proliferate and mount the attack against it. Only some of the
antigens our lymphocytes are programmed to resist will ever invade our bodies. Consequently, only some members of our
army of immunocompetent cells are mobilized in our lifetime.
The others are forever idle.
Our lymphocytes make up to a billion different types of antigen receptors. These receptors, like all other proteins, are specified by genes, so you might think that an individual must have
billions of genes. Not so; each body cell only contains about
25,000 genes that code for all the proteins the cell must make.
How can a limited number of genes generate a seemingly
limitless number of different antigen receptors? Molecular genetic studies have shown that the genes that dictate the structure
of each antigen receptor are not present as such in embryonic
cells. Instead of a complete set of “antigen receptor genes,” embryonic cells contain a few hundred genetic bits and pieces that
can be thought of as a “Lego set” for antigen receptor genes. As
each lymphocyte becomes immunocompetent, these gene segments are shuffled and combined in different ways in a process
called somatic recombination. The information of the newly
assembled genes is then expressed as the surface receptors of
B and T cells and as the antibodies later released by the B cell’s
“offspring.”
Antigen-Presenting Cells
The major role of antigen-presenting cells (APCs) in immunity is to engulf antigens and then present fragments of them,
like signal flags, on their own surfaces where they can be recognized by T cells. In other words, they present antigens to the cells
that will deal with the antigens. The major types of cells acting
as APCs are dendritic cells (present in connective tissues and in
the epidermis, where they are also called Langerhans cells),
macrophages, and B lymphocytes.
Notice that all these cell types are in sites that make it easy to
encounter and process antigens. Dendritic cells are at the body’s
frontiers, best situated to act as mobile sentinels. Macrophages
are widely distributed throughout the lymphoid organs and
connective tissues. When they present antigens, dendritic cells
and macrophages activate T cells. Activated T cells, in turn, release chemicals that prod macrophages to become activated
macrophages, true “killers” that are insatiable phagocytes and secrete bactericidal chemicals. As you will see, interactions between various lymphocytes, and between lymphocytes and
APCs, underlie virtually all phases of the immune response.
Macrophages tend to remain fixed in the lymphoid organs,
as if waiting for antigens to come to them. But lymphocytes, es-
Adaptive defenses
779
Cellular immunity
Positive selection: T cells must recognize self major histocompatibility
proteins (self-MHC).
Antigenpresenting
thymic cell
Developing
T cell
Failure to recognize selfMHC results in apoptosis
(death by cell suicide).
MHC
Self-antigen
T cell receptor
Recognizing self-MHC
results in MHC restriction—
survivors are restricted to
recognizing antigen on
self-MHC. Survivors proceed
to negative selection.
Negative selection: T cells must not recognize self-antigens.
Recognizing self-antigen
results in apoptosis. This
eliminates self-reactive
T cells that could cause
autoimmune diseases.
Failure to recognize (bind
tightly to) self-antigen
results in survival and
continued maturation.
Figure 21.9 T cell education in the thymus.
pecially the T cells (which account for 65–85% of bloodborne
lymphocytes), circulate continuously throughout the body. This
circulation greatly increases a lymphocyte’s chance of coming
into contact with antigens located in different parts of the body,
as well as with huge numbers of macrophages and other lymphocytes. Although lymphocyte recirculation appears to be random, the lymphocyte emigration to the tissues where their
protective services are needed is highly specific, regulated by
homing signals (CAMs) displayed on vascular endothelial cells.
Immune cells in lymph nodes are in a strategic position to
encounter a large variety of antigens because lymphatic capillaries pick up proteins and pathogens from nearly all body tissues. Lymphocytes and APCs in the tonsils act primarily against
microorganisms that invade the oral and nasal cavities, and the
spleen acts as a filter to trap bloodborne antigens.
In addition to T cell recirculation and passive delivery of
antigens to lymphoid organs by lymphatics, a third delivery
21
000200010270575674_R1_CH21_p0766-0803.qxd
780
11/2/2011 02:45 PM Page 780
UN I T 4 Maintenance of the Body
Humoral Immune Response
䉴 Define humoral immunity.
䉴 Describe the process of clonal selection of a B cell.
䉴 Recount the roles of plasma cells and memory cells in humoral immunity.
The antigen challenge, the first encounter between an immunocompetent but naive lymphocyte and an invading antigen, usually takes place in the spleen or in a lymph node, but it
may happen in any secondary lymphoid organ. If the lymphocyte is a B cell, the challenging antigen provokes the humoral immune response, in which antibodies are produced against the
challenger.
Clonal Selection and Differentiation of B Cells
Figure 21.10 Dendritic cell. Scanning electron micrograph (1050⫻).
21
mechanism—migration of dendritic cells to secondary lymphoid organs—is now recognized as the most important way of
ensuring that the immune cells encounter invading antigens.
With their long, wispy extensions, dendritic cells are very efficient antigen catchers (Figure 21.10). Once they have internalized antigens by phagocytosis, they enter nearby lymphatics to
get to the lymphoid organ where they will present the antigens
to T cells. Indeed, dendritic cells are the most effective antigen
presenters known—it’s their only job. Dendritic cells are a key
link between innate and adaptive immunity. They initiate adaptive immune responses particularly tailored to the type of
pathogen that they have encountered.
In summary, the two-fisted adaptive immune system uses
lymphocytes, APCs, and specific molecules to identify and destroy all substances—both living and nonliving—that are in the
body but not recognized as self. The system’s response to such
threats depends on the ability of its cells (1) to recognize antigens in the body by binding to them and (2) to communicate
with one another so that the whole system mounts a response
specific to those antigens.
C H E C K Y O U R U N D E R S TA N D I N G
9. What event (or observation) signals that a B or T cell has
achieved immunocompetence?
10. Which of the following T cells would survive education in
the thymus? (a) one that recognizes neither MHC nor selfantigen, (b) one that recognizes both MHC and self-antigen,
(c) one that recognizes MHC but not self-antigen, (d) one
that recognizes self-antigen but not MHC.
11. Name three different APCs. Which is most important for
T lymphocyte activation?
For answers, see Appendix G.
An immunocompetent but naive B lymphocyte is activated—
stimulated to complete its differentiation—when matching
antigens bind to its surface receptors and cross-link adjacent
receptors together. Antigen binding is quickly followed by
receptor-mediated endocytosis of the cross-linked antigenreceptor complexes. This sequence of steps triggers clonal
selection (klo⬘nul) because it stimulates the B cell to grow and
then multiply rapidly to form an army of cells all exactly like
itself and bearing the same antigen-specific receptors (Figure 21.11). The resulting family of identical cells, all descended from the same ancestor cell, is called a clone. The
antigen does the selecting in clonal selection by “choosing” a
lymphocyte with complementary receptors. (As we will see
shortly, interactions with T cells are usually required to help
B cells achieve full activation.)
Most cells of the clone differentiate into plasma cells, the
antibody-secreting effector cells of the humoral response.
Although B cells secrete limited amounts of antibodies, plasma
cells develop the elaborate internal machinery (largely rough
endoplasmic reticulum) needed to secrete antibodies at the
unbelievable rate of about 2000 molecules per second. Each
plasma cell functions at this breakneck pace for 4 to 5 days and
then dies. The secreted antibodies, each with the same antigenbinding properties as the receptor molecules on the surface of
the parent B cell, circulate in the blood or lymph. There they
bind to free antigens and mark them for destruction by other
innate or adaptive mechanisms.
Clone cells that do not become plasma cells become longlived memory cells. They can mount an almost immediate humoral response if they encounter the same antigen again at
some future time (Figure 21.11, bottom).
Immunological Memory
The cellular proliferation and differentiation we have just described constitute the primary immune response, which occurs
on first exposure to a particular antigen. The primary response
typically has a lag period of 3 to 6 days after the antigen challenge. This lag period mirrors the time required for the few B cells
specific for that antigen to proliferate (about 12 generations) and
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 781
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Adaptive defenses
781
Humoral immunity
Antigen
Primary response
(initial encounter
with antigen)
Activated B cells
Proliferation to
form a clone
Plasma cells
(effector B cells)
Memory B cell—
primed to respond
to same antigen
Secreted
antibody
molecules
Secondary response
(can be years later)
Antigen binding
to a receptor on a
specific B lymphocyte
(B lymphocytes with
non-complementary
receptors remain
inactive)
Clone of cells
identical to
ancestral cells
Subsequent challenge
by same antigen results
in more rapid response
Plasma
cells
Secreted
antibody
molecules
Memory
B cells
Figure 21.11 Clonal selection of a B cell.
for their offspring to differentiate into plasma cells. After the mobilization period, plasma antibody levels rise, reach peak levels in
about 10 days, and then decline (Figure 21.12).
If (and when) someone is reexposed to the same antigen,
whether it’s the second or the twenty-second time, a secondary
immune response occurs. Secondary immune responses are
faster, more prolonged, and more effective, because the immune
system has already been primed to the antigen, and sensitized
memory cells are already in place “on alert.” These memory cells
provide what is commonly called immunological memory.
Within hours after recognition of the “old enemy” antigen, a
new army of plasma cells is being generated. Within 2 to 3 days
the antibody concentration in the blood, called the antibody titer,
rises steeply to reach much higher levels than were achieved in the
primary response. Secondary response antibodies not only bind
with greater affinity (more tightly), but their blood levels remain
high for weeks to months. (When the appropriate chemical signals are present, plasma cells can keep functioning for much
21
longer than the 4 to 5 days seen in primary responses.) Memory
cells persist for long periods in humans and many retain their capacity to produce powerful secondary humoral responses for life.
The same general phenomena occur in the cellular immune
response: A primary response sets up a pool of effector cells (in
this case, T cells) and generates memory cells that can then
mount secondary responses.
Active and Passive Humoral Immunity
䉴 Compare and contrast active and passive humoral immunity.
When your B cells encounter antigens and produce antibodies
against them, you are exhibiting active humoral immunity.
Active immunity is acquired in two ways (Figure 21.13). It is
(1) naturally acquired when you get a bacterial or viral infection, during which time you may develop symptoms of the
disease and suffer a little (or a lot), and (2) artificially acquired
000200010270575674_R1_CH21_p0766-0803.qxd
782
UN I T 4 Maintenance of the Body
Secondary immune response to
antigen A is faster and larger; primary
immune response to antigen B is
similar to that for antigen A.
Primary immune
response to antigen
A occurs after a delay.
Antibody titer (antibody concentration)
in serum (arbitrary units)
11/2/2011 02:45 PM Page 782
Humoral
immunity
Active
Passive
104
103
Naturally
acquired
Infection;
contact with
pathogen
102
101
100
Antibodies
to B
Antibodies
to A
0
7
First exposure
to antigen A
14
21
28
35
42
49
56
Second exposure to antigen A;
first exposure to antigen B
Artificially
acquired
Vaccine;
dead or
attenuated
pathogens
Naturally
acquired
Antibodies
pass from
mother to
fetus via
placenta; or
to infant in
her milk
Artificially
acquired
Injection of
immune
serum
(gamma
globulin)
Figure 21.13 Active and passive humoral immunity.
Immunological memory is established via active immunity, never via
passive immunity.
Time (days)
Figure 21.12 Primary and secondary humoral responses. The
primary response to antigen A generates memory cells that give rise
to the enhanced secondary response to antigen A. The response to
antigen B is independent of the response to antigen A.
when you receive vaccines. Indeed, once researchers realized
that secondary responses are so much more vigorous than
primary responses, the race was on to develop vaccines to
“prime” the immune response by providing a first meeting
with the antigen.
Most vaccines contain pathogens that are dead or attenuated
(living, but extremely weakened), or their components. Vaccines provide two benefits:
21
1. They spare us most of the symptoms and discomfort of
the disease that would otherwise occur during the primary
response.
2. Their weakened antigens provide functional antigenic determinants that are both immunogenic and reactive.
Vaccine booster shots, which may intensify the immune response at later meetings with the same antigen, are also available.
Vaccines have wiped out smallpox and have substantially
lessened the illness caused by such former childhood killers as
whooping cough, polio, and measles. Although vaccines have
dramatically reduced hepatitis B, tetanus, and pneumonia in
adults, immunization of adults in the U.S. has a much lower priority than that of children and as a result more than 65,000
Americans die each year from vaccine-preventable infections
(pneumonia, influenza, and hepatitis).
Conventional vaccines have shortcomings. Although it was
originally believed that the immune response was about the
same regardless of how an antigen got into the body (under its
own power or via a vaccine), that has proved not to be the case.
Apparently vaccines mainly target the type of helper T cell that
revs up B cell defenses and antibody formation (the TH2 cell,
described shortly) as opposed to the type that generates strong
cell-mediated responses (TH1). As a result, lots of antibodies are
formed that provide immediate protection, but cellular immunological memory is only poorly established. (The immune
system is deprived of the learning experience that comes with
clearing an infection via a TH1-mediated response.)
In extremely rare cases, vaccines cause the very disease they
are trying to prevent because the attenuated virus isn’t weakened enough. In other cases, contaminating proteins (for example, egg albumin) cause allergic responses to the vaccine. The
new “naked DNA” antiviral vaccines, blasted into the skin with a
gene gun, and edible vaccines taken orally appear to circumvent
these problems.
Passive humoral immunity differs from active immunity,
both in the antibody source and in the degree of protection it
provides (Figure 21.13). Instead of being made by your plasma
cells, the antibodies are harvested from the serum of an immune human or animal donor. As a result, your B cells are not
challenged by antigens, immunological memory does not occur,
and the protection provided by the “borrowed” antibodies ends
when they naturally degrade in the body.
Passive immunity is conferred naturally on a fetus or infant
when the mother’s antibodies cross the placenta or are ingested
with the mother’s milk. For several months after birth, the baby
is protected from all the antigens to which the mother has been
exposed. Passive immunity is artificially conferred via a serum
such as gamma globulin, which is administered after exposure to
hepatitis. Other immune sera are used to treat poisonous snake
bites (antivenom), botulism, rabies, and tetanus (antitoxin) because these rapidly fatal diseases would kill a person before active immunity could be established. The donated antibodies
provide immediate protection, but their effect is short-lived
(two to three weeks).
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 783
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Adaptive defenses
783
Humoral immunity
ea
H
Antigen-binding
site
vy
ch
ai
n
Li
gh
ha
tc
in
Heavy chain
variable region
Heavy chain
constant region
Hinge region
Light chain
variable region
Stem region
Light chain
constant region
Disulfide bond
(a)
(b)
Figure 21.14 Antibody structure. (a) Schematic antibody structure (based on IgG) consists
of four polypeptides—two short light chains and two long heavy chains joined together by
disulfide bonds (S–S). Each chain has a V (variable) region (which differs in antibodies from different
cells) and a C (constant) region (essentially identical in different antibodies of the same class).
Together, the variable regions form the antigen-binding sites—two per antibody monomer.
(b) Computer-generated image of antibody structure.
C H E C K Y O U R U N D E R S TA N D I N G
12. In clonal selection, “who” does the selecting? What is being
selected?
13. Why is the secondary response to an antigen so much faster
than the primary response?
14. How do vaccinations protect against common childhood illnesses such as chicken pox, measles, and mumps?
For answers, see Appendix G.
Antibodies
䉴 Describe the structure of an antibody monomer, and name
the five classes of antibodies.
䉴 Explain the function(s) of antibodies and describe clinical
uses of monoclonal antibodies.
Antibodies, also called immunoglobulins (Igs) (im⬙u-noglob⬘u-linz), constitute the gamma globulin part of blood proteins. As we mentioned earlier, antibodies are proteins secreted
in response to an antigen by effector B cells called plasma cells,
and they are capable of binding specifically with that antigen.
They are formed in response to an incredible number of different antigens.
Despite their variety, all antibodies can be grouped into one
of five Ig classes, each slightly different in structure and function. Before seeing how these Ig classes differ from one another,
let’s take a look at how all antibodies are alike.
Basic Antibody Structure
Regardless of its class, each antibody has a basic structure consisting of four looping polypeptide chains linked together by
disulfide (sulfur-to-sulfur) bonds. The four chains combined
form a molecule, called an antibody monomer (mon⬘o-mer),
with two identical halves. The molecule as a whole is T or Y shaped
(Figure 21.14).
Two of the chains, called the heavy (H) chains, are identical to each other and contain more than 400 amino acids each
(blue chains in Figure 21.14a). The other two chains, called
the light (L) chains (pink), are also identical to each other,
but they are only about half as long as each H chain. The
heavy chains have a flexible hinge region at their approximate
“middles.” The “loops” on each chain are created by disulfide
bonds between amino acids that are in the same chain but
about 60–70 amino acids apart. These bonds cause the intervening parts of the polypeptide chains to loop out.
Each chain forming an antibody has a variable (V) region at
one end and a much larger constant (C) region at the other end.
Antibodies responding to different antigens have very different
V regions, but their C regions are the same (or nearly so) in all
antibodies of a given class. In each arm of the monomer, the
V regions of the heavy and light chains combine to form an
antigen-binding site shaped to “fit” a specific antigenic determinant. Consequently, each antibody monomer has two such
antigen-binding regions.
The C regions that form the stem of the antibody monomer
determine the antibody class and serve common functions in
21
000200010270575674_R1_CH21_p0766-0803.qxd
784
11/2/2011 02:45 PM Page 784
UN I T 4 Maintenance of the Body
TABLE 21.3
Immunoglobulin Classes
IgM
(pentamer)
IgA
(dimer)
IgD
(monomer)
IgG
(monomer)
21
IgE
(monomer)
IgM exists in monomer and pentamer
(five united monomers) forms. The
monomer, which is attached to the
B cell surface, serves as an antigen
receptor. The pentamer (illustrated)
circulates in blood plasma and is the
first Ig class released by plasma cells
during the primary response. (This
fact is diagnostically useful because
presence of IgM in plasma usually
indicates current infection by the
pathogen eliciting IgM’s formation.)
Its numerous antigen-binding sites
make IgM a potent agglutinating
agent, and it readily fixes and activates complement.
IgA monomer exists in limited amounts
in plasma. The dimer (illustrated), referred to as secretory IgA, is found in
body secretions such as saliva, sweat,
intestinal juice, and milk, and helps
prevent attachment of pathogens to
epithelial cell surfaces (including mucous membranes and the epidermis).
IgD is virtually always attached to the
external surface of a B cell, where it
functions as an antigen receptor of
the B cell.
IgG is the most abundant and diverse
antibody in plasma, accounting for
75–85% of circulating antibodies. It
protects against bacteria, viruses, and
toxins circulating in blood and lymph,
readily fixes complement, and is the
main antibody of both secondary and
late primary responses. It crosses the
placenta and confers passive immunity
from the mother to the fetus.
IgE is slightly larger than the IgG antibody. It is secreted by plasma cells in
skin, mucosae of the gastrointestinal
and respiratory tracts, and tonsils. Its
stem region becomes bound to mast
cells and basophils, and when its receptor ends are triggered by an antigen, it causes the cells to release
histamine and other chemicals that
mediate inflammation and an allergic reaction. Typically only traces of
IgE are found in plasma, but levels
rise during severe allergic attacks or
chronic parasitic infections of the gastrointestinal tract.
primarily in body secretions, some cross the placental barrier,
and so on.
Antibody Classes
The five major immunoglobulin classes are designated IgM,
IgA, IgD, IgG, and IgE, on the basis of the C regions in their
heavy chains. (Remember the name MADGE to recall the five
Ig types.) Compared to the other antibodies, IgM is a huge antibody. It is constructed from five Y-shaped units, or monomers,
linked together to form a pentamer (penta ⫽ five), as illustrated
in Table 21.3. IgA occurs in both monomer and dimer (two
linked monomers) forms. (Only the dimer is shown in the
table.) IgD, IgG, and IgE are monomers and have the same basic
Y-shaped structure.
The antibodies of each class have different biological roles
and locations in the body. IgM is the first antibody class released
to the blood by plasma cells. It readily fixes complement. The
IgA dimer, also called secretory IgA, is found primarily in mucus and other secretions that bathe body surfaces. It plays a major role in preventing pathogens from gaining entry into the
body. IgD is always bound to a B cell surface, where it acts as a
B cell receptor. IgG is the most abundant antibody in plasma
and the only Ig class that crosses the placental barrier. For this
reason, the passive immunity that a mother transfers to her
fetus is courtesy of her IgG antibodies. Like IgM, IgG can fix
complement, and only these two antibody classes can do so. IgE
antibodies, found in minute quantities in blood, are the “troublemaker” antibodies involved in some allergies. These and
other characteristics unique to each immunoglobulin class are
summarized in Table 21.3.
Generating Antibody Diversity
Recall from p. 779 that the billions of different kinds of antibodies produced by plasma cells come about as the result of somatic
recombination of a limited number of gene segments. The random mixing of gene segments that code for the antigen-binding
site (variable regions) accounts for only part of the huge variability seen in antibody specificity. Certain areas of one gene
segment in activated B cells contain hypervariable regions that
are “hot spots” for somatic mutations, and that enormously
increase antibody variation.
A single plasma cell can switch from making one kind of
H chain to making another kind, thereby producing two or
more different antibody classes having the same antigen
specificity. For example, the first antibody released in the
primary response is IgM, and then the plasma cell begins to
secrete IgG. During secondary responses, almost all of the Ig
protein is IgG.
Antibody Targets and Functions
all antibodies: These are the effector regions of the antibody
that dictate (1) the cells and chemicals of the body the antibody can bind to, and (2) how the antibody class functions in
antigen elimination. For example, some antibodies can fix
complement, some circulate in blood and others are found
Though antibodies themselves cannot destroy antigens, they
can inactivate them and tag them for destruction (Figure 21.15).
The common event in all antibody-antigen interactions is formation of antigen-antibody (or immune) complexes. Defensive mechanisms used by antibodies include neutralization,
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 785
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Adaptive defenses
Humoral immunity
Antigen
Antigen-antibody
complex
Antibody
Inactivates by
Neutralization
(masks dangerous
parts of bacterial
exotoxins; viruses)
785
Fixes and activates
Agglutination
(cell-bound antigens)
Enhances
Precipitation
(soluble antigens)
Enhances
Phagocytosis
Complement
Leads to
Inflammation
Cell lysis
Chemotaxis
Histamine
release
Figure 21.15 Mechanisms of antibody action. Antibodies act against free viruses, red blood
cell antigens, bacterial toxins, intact bacteria, fungi, and parasitic worms.
21
agglutination, precipitation, and complement fixation, with the
first two most important.
Neutralization, the simplest defensive mechanism, occurs
when antibodies block specific sites on viruses or bacterial exotoxins (toxic chemicals secreted by bacteria). As a result, the
virus or exotoxin loses its toxic effect because it cannot bind to
receptors on tissue cells to cause injury. The antigen-antibody
complexes are eventually destroyed by phagocytes.
Because antibodies have more than one antigen-binding
site, they can bind to the same determinant on more than one
antigen at a time. Consequently, antigen-antibody complexes
can be cross-linked into large lattices. When cell-bound antigens are cross-linked, the process causes clumping, or
agglutination, of the foreign cells. IgM, with 10 antigenbinding sites, is an especially potent agglutinating agent (see
Table 21.3). Recall from Chapter 17 that this type of reaction
occurs when mismatched blood is transfused (the foreign red
blood cells are clumped) and is the basis of tests used for
blood typing.
In precipitation, soluble molecules (instead of cells) are
cross-linked into large complexes that settle out of solution.
Like agglutinated bacteria, precipitated antigen molecules are
much easier for phagocytes to capture and engulf than are freely
moving antigens.
Complement fixation and activation is the chief antibody
defense used against cellular antigens, such as bacteria or mismatched red blood cells. When several antibodies bind close together on the same cell, the complement-binding sites on their
stem regions align. This triggers complement fixation into the
antigenic cell’s surface, followed by cell lysis. Additionally, as we
described earlier, molecules released during complement activation tremendously amplify the inflammatory response and
promote phagocytosis via opsonization. In this way, a positive
feedback cycle that enlists more and more defensive elements is
set into motion.
A quick and dirty way to remember how antibodies work is
to remember they have a PLAN of action—precipitation, lysis
(by complement), agglutination, and neutralization.
000200010270575674_R1_CH21_p0766-0803.qxd
786
11/2/2011 02:45 PM Page 786
UN I T 4 Maintenance of the Body
H O M E O S TAT I C I M B A L A N C E
Around the world, billions of people are infected by parasitic
worms such as Ascaris and Schistosoma. These large pathogens
are difficult for our immune systems to deal with and “PLAN” is
insufficient. Nevertheless, antibodies still play a critical role in
the worm’s destruction. IgE antibodies coat the surface of parasitic worms, marking them for destruction by eosinophils.
When eosinophils encounter antibody-coated worms, they
bind to the exposed stems of the IgE. This triggers the
eosinophils to release the toxic contents of their large cytoplasmic granules all over their prey. ■
Monoclonal Antibodies
In addition to their role in providing passive immunity, commercially prepared antibodies are used in research, clinical
testing, and treatment. Monoclonal antibodies, used for such
purposes, are produced by descendants of a single cell. They
are pure antibody preparations specific for a single antigenic
determinant.
Monoclonal antibodies are made by fusing tumor cells and
B lymphocytes. The resulting cell hybrids, called hybridomas
(hi⬙brı̆-do⬘mahz), have desirable traits of both parent cells. Like
tumor cells, hybridomas proliferate indefinitely in culture, and
like B cells, they produce a single type of antibody.
Monoclonal antibodies are used to diagnose pregnancy, certain sexually transmitted diseases, some types of cancer, hepatitis,
and rabies. These monoclonal antibody tests are more specific,
more sensitive, and faster than their conventional counterparts.
Monoclonal antibodies are also being used to treat leukemia and
lymphomas, cancers that are present in the circulation and so are
easily accessible to injected antibodies. They also serve as “guided
missiles” to deliver anticancer drugs only to cancerous tissue, and
to treat certain autoimmune diseases (as we will discuss later).
C H E C K Y O U R U N D E R S TA N D I N G
21
15. Which class of antibody is most abundant in blood? Which is
secreted first in a primary immune response? Which is most
abundant in secretions?
16. List four ways in which antibodies can bring about destruction of a pathogen.
For answers, see Appendix G.
Cell-Mediated Immune Response
䉴 Follow antigen processing in the body.
䉴 Define cell-mediated immunity and describe the process of
activation and clonal selection of T cells.
Despite their immense versatility, antibodies provide only partial immunity. Their prey is the obvious pathogen. They are
fairly useless against infectious microorganisms like viruses and
the tuberculosis bacillus that quickly slip inside body cells to
multiply there. In these cases, the cell-mediated arm of adaptive
immunity comes into play.
The T cells that mediate cellular immunity are a diverse lot,
much more complex than B cells in both classification and function. There are two major populations of T cells based on which
of a pair of structurally related cell differentiation glycoproteins—
CD4 or CD8—is displayed by a mature T cell. These glycoproteins are surface receptors but are distinct from the T cell
antigen receptors. They play a role in interactions between T cells
and other cells.
When activated, CD4 and CD8 cells differentiate into the two
major kinds of effector cells of cellular immunity (as well as
memory cells). CD4 cells usually become helper T cells (TH).
On the other hand, CD8 cells become cytotoxic T cells (TC)
whose role is to destroy any cells in the body that harbor anything foreign (Figure 21.16). In addition to these two major
groups of effector T cells, there are regulatory T cells (TReg),
memory T cells, and some fairly rare subgroups. We will provide details of T cells’ roles shortly.
Before going into the details of the cell-mediated immune response, let’s recap and compare the relative importance of the
humoral and cellular responses in adaptive immunity. Antibodies, produced by plasma cells, are in many ways the simplest ammunition of the immune response. They are specialized to latch
onto intact bacteria and soluble foreign molecules in extracellular environments—in other words, free in body secretions and
tissue fluid and circulating in blood and lymph. Antibodies
never invade solid tissues unless a lesion is present.
At the most basic level, the race between antibody production and pathogen multiplication determines whether or not
you become sick. Remember, however, that forming antibodyantigen complexes does not destroy the antigens. Instead, it prepares them for destruction by innate defenses.
In contrast to B cells and antibodies, T cells cannot “see”
either free antigens or antigens that are in their natural state.
T cells can recognize and respond only to processed fragments of
protein antigens displayed on surfaces of body cells (APCs and
others). Consequently, T cells are best suited for cell-to-cell
interactions. Their direct attacks on antigens (mediated by the
cytotoxic T cells) target body cells infected by viruses or bacteria; abnormal or cancerous body cells; and cells of infused or
transplanted foreign tissues.
Clonal Selection and Differentiation of T Cells
The stimulus for clonal selection and differentiation is the same
in B cells and T cells—binding of antigen. However, the mechanism by which T cells recognize “their” antigen is very different
than that in B cells and has some unique restrictions.
MHC Proteins and Antigen Presentation
Like B cells, immunocompetent T cells are activated when the
variable regions of their surface receptors bind to a “recognized”
antigen. However, T cells must accomplish double recognition:
They must simultaneously recognize nonself (the antigen) and
self (an MHC protein of a body cell).
Two types of MHC proteins are important to T cell activation.
Class I MHC proteins are displayed by virtually all body cells
except red blood cells and are recognized by cytotoxic (CD8)
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 787
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Adaptive defenses
787
Cellular immunity
Immature
lymphocyte
Red bone marrow
T cell
receptor
Class II MHC
protein
T cell
receptor
Maturation
CD8
cell
CD4
cell
Class I MHC
protein
Thymus
Activation
Activation
APC
(dendritic cell)
Memory
cells
APC
(dendritic cell)
CD8
CD4
Lymphoid
tissues and
organs
Helper T cells
(or regulatory T cells)
Effector
cells
Cytotoxic T cells
Blood plasma
Figure 21.16 Major types of T cells based on displayed cell differentiation glycoproteins
(CD4, CD8).
T cells. A class I MHC protein is synthesized at the endoplasmic
reticulum and then binds with a protein fragment 8 or 9 amino
acids long that is ferried into the ER from the cytosol by special
transport proteins. The “loaded” class I MHC protein then migrates to the plasma membrane to display its attached protein
fragment.
The attached fragment is always part of some protein synthesized in the cell—either a bit of a cellular (self) protein or a peptide derived from a foreign protein synthesized in a body cell.
Both are called an endogenous antigen. The endogenous antigens are broken down to peptides within a proteasome before
they are loaded onto MHCs. Two examples of endogenous foreign antigens are the viral proteins produced by virus-infected
cells and alien (mutated) proteins made by a body cell that has
become cancerous. Figure 21.17a summarizes the processing
and display of endogenous antigens on class I MHC proteins.
The role of class I MHC proteins in the immune response is
crucially important because they provide the means for signaling to cytotoxic T cells that infectious microorganisms are hiding in body cells. Without such means, viruses and certain
bacteria that thrive in cells could multiply unnoticed and unbothered. When class I MHC proteins display fragments of our
own proteins (self-antigens), cytotoxic T cells passing by get the
signal “Leave this cell alone, it’s ours!” and ignore them. But
when class I MHC proteins display foreign antigens, they betray
the invaders and “sound a molecular alarm” that signals invasion.
21
000200010270575674_R1_CH21_p0766-0803.qxd
788
11/2/2011 02:45 PM Page 788
UN I T 4 Maintenance of the Body
Cytoplasm of any tissue cell
1 Endogenous antigen
is degraded by protease.
Cisternae of
endoplasmic
reticulum (ER)
2 Endogenous antigen peptides
enter ER via transport protein.
3 Endogenous antigen
peptide is loaded onto
class I MHC protein.
ATP
Endogenous antigen —
self-protein or foreign
(viral or cancer) protein
sI
Clas C
MH
Transport
protein
(ATPase)
4 Loaded MHC protein
migrates in vesicle to the
plasma membrane, where it
displays the antigenic peptide.
Class I
MHC
Antigenic peptide
Plasma membrane of a tissue cell
Extracellular fluid
(a) Endogenous antigens are processed and displayed on class I MHC of all cells.
Cytoplasm of APC
1a Class II MHC is
synthesized in ER.
Invariant chain prevents
class II MHC from binding
to peptides in the ER.
Class II
MHC
Cisternae of
endoplasmic
reticulum (ER)
21
2a Class II MHC is
exported from ER
in a vesicle.
Class II
MHC
3 Vesicle fuses with phagolysosome.
Invariant chain is removed, and
antigen is loaded.
Phagosome
1b Extracellular antigen
(bacterium) is phagocytized.
Class II
MHC
2b Phagosome merges
with lysosome, forming a
phagolysosome; antigen
is degraded.
Extracellular
antigen
4 Vesicle with loaded
MHC migrates to the
plasma membrane.
Lysosome
Plasma membrane of APC
Extracellular fluid
(b) Exogenous antigens are processed and displayed on class II MHC of antigen-presenting cells (APCs).
Figure 21.17 MHC proteins, and antigen processing and display.
Class II
MHC
Antigenic peptide
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 789
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
In this signaling, the class I MHC proteins both (1) act as antigen holders and (2) form the self part of the self-nonself complexes that cytotoxic T cells must recognize in order to kill.
Unlike the widely distributed class I MHC proteins, the second type of MHC protein is less widespread. Class II MHC proteins are typically found only on the surfaces of cells that present
antigens to CD4 cells: dendritic cells, macrophages, and B cells.
Like their class I MHC counterparts, class II MHC proteins are
synthesized at the ER and bind to peptide fragments. However,
the peptides they bind are longer (14–17 amino acids) and come
from exogenous antigens (antigens from outside the cell) that
have been engulfed and broken down in the phagolysosome.
Figure 21.17b summarizes how exogenous antigens are
processed and displayed. While still in the ER, each class II MHC
molecule binds a protein called an invariant chain. This coupling prevents the MHC molecule from binding to a peptide
while in the ER. The class II MHC protein then moves from the
ER through the Golgi apparatus and into a phagolysosome.
There the invariant chain loosens its hold on the MHC molecule, allowing the “jaws” of MHC to close around a degraded
exogenous protein fragment. The vesicle is then recycled to the
cell surface, where the class II MHC protein displays its booty
for CD4 cells to recognize.
Adaptive defenses
Antigen Binding This first step mostly entails what we have
already described: T cell antigen receptors (TCRs) bind to an
antigen-MHC complex on the surface of an APC. Like B cell receptors, a TCR has variable and constant regions, but it consists
of two rather than four polypeptide chains.
CD4 and CD8 cells have different requirements for the class
of MHC protein that helps deliver the activation signal. This
constraint, acquired during the education process in the thymus, is called MHC restriction. CD4 cells (that usually become
helper T cells) can bind only to antigens linked to class II MHC
proteins, which are typically displayed on APC surfaces (Figure 21.18). CD8 cells (that become cytotoxic T cells) are activated by antigen fragments complexed with class I MHC
proteins, also found on the surface of APCs.
The MHC restriction that we’ve just described presents a
problem for APCs. As a rule, class I MHC proteins display endogenous antigens—those that originate inside that cell. How
do APCs obtain endogenous antigens from another cell and display them on class I MHCs in order to activate CD8 cells? Dendritic cells have the special ability to do this. They obtain other
cells’ endogenous antigens by either engulfing dying virusinfected or tumor cells, or by importing antigens through
1 Dendritic cell
engulfs an
exogenous
antigen,
processes it, and
displays its
fragments on
class II MHC
protein.
Class lI MHC
protein
displaying
processed
viral antigen
CD4 protein
T cell receptor
(TCR)
Clone
formation
Immunocompetent CD4
T cell
2 Immunocompetent CD4
cell recognizes
antigen-MHC
complex. Both
TCR and CD4
protein bind to
antigen-MHC
complex.
3 CD4 cells are
activated,
proliferate (clone),
and become
memory and
effector cells.
T Cell Activation
T cell activation is actually a two-step process involving antigen
binding and co-stimulation. Both steps usually occur on the
surface of the same antigen-presenting cell (APC). As we described earlier, dendritic cells are the most potent APCs, displaying very small parts of antigens attached to their surface MHC
proteins for recognition. In addition, dendritic cells migrate to
the lymph nodes and other lymphoid tissues to present their
antigens to T cells. As a result of this early alert, the body is
spared a good deal of tissue damage that might otherwise occur.
Cellular immunity
Viral antigen
Dendritic
cell
789
Helper T
memory cell
Activated
helper
T cells
Figure 21.18 Clonal selection of T cells involves simultaneous
recognition of self and nonself. Activation of CD4 cells is shown
here, but activation of CD8 cells is similar. Co-stimulation (also
essential for activation) is not shown.
temporary gap junctions with infected cells. Dendritic cells then
display these antigens on both class I and class II MHCs.
The TCR that recognizes the nonself-self complex is linked
to multiple intracellular signaling pathways. Besides the TCR,
other T cell surface proteins are involved in this first step. For example, the CD4 and CD8 proteins used to identify the two major T cell groups are adhesion molecules that help maintain the
coupling during antigen recognition. Additionally, the CD4 and
CD8 proteins are associated with kinase enzymes located inside
the T cells that phosphorylate cell proteins, activating some and
inactivating others when antigen binding occurs. Once antigen
binding has occurred, the T cell is stimulated but is still “idling,”
like a car that has been started but not put into gear.
The story isn’t over yet because step 2 comes
next. Before a T cell can proliferate and form a clone, it must
recognize one or more co-stimulatory signals. This requires
T cell binding to still other surface receptors on an APC. For
example, dendritic cells and macrophages begin to sprout
B7 proteins on their surfaces when the innate defenses are being
mobilized. B7 binding to the CD28 receptor on a T cell is a crucial co-stimulatory signal.
Co-stimulation
21
000200010270575674_R1_CH21_p0766-0803.qxd
790
UN I T 4 Maintenance of the Body
TABLE 21.4
Selected Cytokines
CYTOKINE
FUNCTION IN IMMUNE RESPONSE
Interferons (IFNs)
■ Alpha (␣) and
beta (␤)
Secreted by many cells. Have antiviral effects; activate NK cells.
■
Gamma (␥)
Interleukins (ILs)
■ IL-1
21
11/2/2011 02:45 PM Page 790
Secreted by lymphocytes. Activates macrophages; stimulates synthesis and expression of more class I and II MHC
proteins; promotes differentiation of TH cells into TH1.
Secreted by activated macrophages. Promotes inflammation and T cell activation; causes fever (a pyrogen that resets
the thermostat of the hypothalamus).
■
IL-2
Secreted by TH cells. Stimulates proliferation of T and B cells; activates NK cells.
■
IL-4
Secreted by some TH cells. Promotes differentiation to TH2; promotes B cell activation; switches antibody production
to IgE.
■
IL-5
Secreted by some TH cells and mast cells. Attracts and activates eosinophils; causes plasma cells to secrete IgA
antibodies.
■
IL-10
Secreted by macrophages and TReg cells. Inhibits macrophages and dendritic cells; turns down cellular and innate
immune response.
■
IL-12
Secreted by dendritic cells and macrophages. Stimulates TC and NK cell activity; promotes TH1 differentiation.
■
IL-17
Secreted by TH17 cells. Important in innate and adaptive immunity and recruitment of neutrophils. Involved in
inflammation in some autoimmune diseases.
Suppressor factors
A generic term for a number of cytokines that suppress the immune system, for example TGF-␤ and IL-10.
Transforming growth
factor beta (TGF-␤)
A suppressor factor similar to IL-10.
Tumor necrosis
factors (TNFs)
Produced by lymphocytes and in large amounts by macrophages. Promote inflammation; enhance phagocyte
chemotaxis and nonspecific killing; slow tumor growth by selectively damaging tumor blood vessels; promote cell
death by apoptosis.
After co-stimulation, cytokine chemicals such as interleukin
1 and 2 released by APCs or T cells themselves nudge the activated T cells to proliferate and differentiate. As you might guess,
there are several types of cytokines, each type promoting a different response in the activated T cells.
What happens if a T cell binds to antigen without receiving
the co-stimulatory signal? In this case, the T cell becomes tolerant to that antigen and is unable to divide or to secrete cytokines.
This state of unresponsiveness to antigen is called anergy.
The two-signal sequence acts as a safeguard to prevent the
immune system from destroying healthy cells. Without this
safeguard, class I MHC proteins, which occur on all body cells
and which display peptides from within the cell, could activate
cytotoxic T cells, leading to widespread damage of healthy cells.
The important thing to understand is that along with antigen
binding, co-stimulation is crucial for T cell activation. To go
back to our idling car analogy, the car will not go anywhere unless the car has both (1) been started and (2) put into gear.
Once activated, a T cell enlarges and proliferates to form a clone
of cells that differentiate and perform functions according to their
T cell class. This primary response peaks within a week of exposure to the triggering antigen. A period of apoptosis then occurs
between days 7 and 30, during which time the activated T cells die
off and effector activity wanes as the amount of antigen declines.
This wholesale disposal of T cells has a critical protective role
because activated T cells are potential hazards. They produce
huge amounts of inflammatory cytokines, which contribute to
infection-driven hyperplasia, and may promote malignancies in
chronically inflamed tissue. Additionally, once they’ve done
their job, the effector T cells are unnecessary and thus disposable. Thousands of clone members become memory T cells,
persisting perhaps for life, and providing a reservoir of T cells
that can later mediate secondary responses to the same antigen.
Cytokines
The chemical messengers involved in cellular immunity belong
to a group of molecules called cytokines, a general term for mediators that influence cell development, differentiation, and responses in the immune system. Cytokines include interferons
and interleukins. In Table 21.4, you can see the large variety of
these molecules and their myriad effects on target cells.
The cytokines include hormone-like or paracrine-like glycoproteins released by a variety of cells. As we mentioned previously, some cytokines act to promote T cell proliferation. For
example, interleukin 1 (IL-1), released by macrophages, stimulates bound T cells to liberate interleukin 2 (IL-2) and to synthesize more IL-2 receptors. IL-2 is a key growth factor. Acting
on the cells that release it (as well as other T cells), it sets up a
positive feedback cycle that encourages activated T cells to divide even more rapidly. (Therapeutically, IL-2 is used to treat
melanoma and kidney cancers.)
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 791
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Additionally, all activated T cells secrete one or more other
cytokines that help amplify and regulate a variety of adaptive
and innate immune responses. Some (such as tumor necrosis
factor) are cell toxins. Others (e.g., gamma interferon) enhance
the killing power of macrophages; and still others are inflammatory factors.
C H E C K Y O U R U N D E R S TA N D I N G
17. Class II MHC proteins display what kind of antigens? What
class of T cell recognizes antigens bound to class II MHC?
What types of cells display these proteins?
18. What happens when antigens are bound in the absence of
co-stimulators?
For answers, see Appendix G.
Adaptive defenses
Humoral immunity
Cellular immunity
TH cell help in humoral immunity
Activated helper
T cell
1 TH cell binds
with the self-nonself
complexes of a B cell
that has encountered
its antigen and is
displaying it on
MHC II on its surface.
T cell receptor (TCR)
Helper T cell
CD4 protein
MHC II protein
of B cell displaying
processed antigen
2 TH cell releases
interleukins as costimulatory signals to
complete B cell
activation.
IL- 4 and other
cytokines
Specific Effector T Cell Roles
B cell (being activated)
䉴 Describe T cell functions in the body.
(a)
When immunocompetent CD4 cells are activated, their offspring become effector cells (cells that carry out T cell functions) or memory cells (cells that cause faster, more prolonged
responses upon a second encounter with an antigen). As we
mentioned earlier, effector CD4 cells are helper or regulatory
T cells, and effector CD8 cells are cytotoxic T cells. There are
other minor “oddball” populations of effector T cells, but here
we will focus on the three major groups.
TH cell help in cell-mediated immunity
CD4 protein
Helper T cell
Class II MHC
protein
APC (dendritic cell)
IL-2
Helper T Cells
Helper T cells play a central role in adaptive immunity, mobilizing both its cellular and its humoral arms, as the examples in
Figure 21.19 show. Once TH cells have been primed by APC
presentation of antigen, they help activate B and T cells, and induce B and T cell proliferation. In fact, without the “director”
TH cells, there is no adaptive immune response. They also activate macrophages to become more potent killers, and their cytokines furnish the chemical help needed to recruit other
immune cells to fight off intruders.
Helper T cells interact directly with B cells displaying antigen
fragments bound to class II MHC receptors (Figure 21.19a).
They prod the B cells into more rapid division and then, like
the boss of an assembly line, signal for antibody formation to
begin. Whenever a TH cell binds to a B cell, the T cell releases
interleukin 4 and other cytokines. B cells may be activated
solely by binding to certain antigens called T cell–independent
antigens, but most antigens require T cell help to activate the
B cells to which they bind. These more common antigens are
called T cell–dependent antigens. In general, T cell–independent
antigen responses are weak and short-lived. B cell division continues as long as it is stimulated by the TH cell. In this way,
helper T cells help unleash the protective potential of B cells.
Similarly, activating CD8 cells into destructive cytotoxic T cells
usually requires help from TH cells. As shown in Figure 21.19b,
TH cells cause dendritic cells to express on their surfaces the costimulatory molecules required for CD8 cell activation.
791
Class I
MHC protein
CD8
protein
CD8 T cell
1 Previously
activated TH cell
binds dendritic cell.
2 TH cell
stimulates dendritic
cell to express
co-stimulatory
molecules (not
shown) needed to
activate CD8 cell.
3 Dendritic cell
can now activate
CD8 cell with the
help of interleukin 2
secreted by TH cell.
(b)
Figure 21.19 The central role of helper T cells in mobilizing
both humoral and cellular immunity. (a) TH and B cells usually
must interact directly for full B cell activation. (b) Co-stimulatory
molecules required for CD8 T cell activation are expressed by
dendritic cells in response to TH cell binding. (Some types of antigens
induce these co-stimulatory molecules themselves, in which case TH
cell help may not be needed.) The TH cell also produces interleukin
2, which causes the CD8 cell to proliferate and differentiate.
Cytokines released by TH cells not only mobilize lymphocytes and macrophages but also attract other types of white
blood cells into the area and tremendously amplify innate defenses. As the released chemicals summon more and more cells
into the battle, the immune response gains momentum, and the
antigens are overwhelmed by the sheer numbers of immune elements acting against them.
It is interesting, but not surprising, that different subsets of
helper T cells exist. The subset that develops during TH cell
21
000200010270575674_R1_CH21_p0766-0803.qxd
792
11/2/2011 02:45 PM Page 792
UN I T 4 Maintenance of the Body
differentiation depends on the type of antigen and the site at
which it is encountered as well as the cytokine exposure of the
differentiating TH cell. For example, IL-12 induces TH1 differentiation, while IL-4 drives TH2 differentiation. Generally speaking, the TH1 cells stimulate inflammation, activate macrophages,
and promote differentiation of cytotoxic T cells. In other words,
they mediate classical cell-mediated immunity. By contrast, TH2
cells mainly promote defense against extracellular pathogens. In
particular, they mobilize eosinophils to the battlefield and activate immune responses that depend on B cells and antibody formation. A third type of TH cell, TH17, links together adaptive and
innate immunity by releasing IL-17, which promotes inflammatory responses and may underlie some autoimmune diseases.
Cytotoxic T Cells
21
Cytotoxic T cells are the only T cells that can directly attack and
kill other cells. Activated TC cells roam the body, circulating in
and out of the blood and lymph and through lymphoid organs
in search of body cells displaying antigens that the TC cells recognize. Their main targets are virus-infected cells, but they also
attack tissue cells infected by certain intracellular bacteria or
parasites, cancer cells, and foreign cells introduced into the body
by blood transfusions or organ transplants.
Before the onslaught can begin, the cytotoxic T cell must
“dock” on the target cell by binding to a self-nonself complex.
Remember, all body cells display class I MHC antigens, so all infected or abnormal body cells can be destroyed by these T cells.
The attack on foreign human cells, such as those of a graft, is
more difficult to explain because here all of the antigens are
nonself. However, apparently the TC cells sometimes “see” the
foreign class I MHC antigens as a combination of self class I
MHC protein bound to foreign antigen.
Once cytotoxic T cells recognize their targets, how do they deliver a lethal hit? There are two major mechanisms. One involves
perforins and granzymes and is illustrated in Figure 21.20a.
Another mechanism of killing by cytotoxic cells involves binding
to a specific membrane receptor (a Fas receptor) on the target
cell, an event that stimulates the target cell to undergo apoptosis.
NK cells use the same key mechanisms for killing their target
cells. NK cells, however, do not look for foreign antigen displayed
on class I MHC proteins. Instead they search for other signs of
abnormality, including the lack of class I MHC or the presence of
antibody coating the target cell. Stressed cells also often express
different surface markers (such as some belonging to a family
called MIC), which can activate NK cells. In short, NK cells stalk
abnormal or foreign cells in the body that TC cells can’t “see.”
NK and TC lymphocytes roam the body, adhering to and
crawling over the surfaces of other cells, examining them for
markers they might recognize, a process called immune surveillance. NK cells check to make sure each cell has “identity flags”
(class I MHC proteins inhibit NK cell attack), whereas TC cells
check the “identity flags” to see if they look the way they are supposed to (foreign antigens stimulate TC cell attack).
Regulatory T Cells
In contrast to the role of TH cells in activating adaptive immunity, related T cells called regulatory T (TReg) cells dampen the
immune response. They act either by direct contact or by releasing inhibitory cytokines such as IL-10 and TGF-␤. TReg cells are
important in preventing autoimmune reactions because they
suppress self-reactive lymphocytes in the periphery—that is,
outside the lymphoid organs. The function and development
of these cells and their subpopulations is currently a hot research topic. For example, researchers hope to use TReg cells to
induce tolerance to transplanted tissue and to lessen the severity
of autoimmune diseases.
■ ■ ■
In summary, each type of T cell has unique roles to play in the
immune response, yet is heavily enmeshed in interactions with
other immune cells and elements as summarized in Table 21.5
and in the overview of the entire primary immune response in
Figure 21.21. The lesson to take away with you is that without
helper T cells, there is no adaptive immune response because the
helper cells direct or help complete the activation of both B cells
and T cells. Their crucial role in immunity is painfully evident
when they are destroyed, as in AIDS (see p. 796).
Organ Transplants and Prevention of Rejection
䉴 Indicate the tests ordered before an organ transplant is
done, and methods used to prevent transplant rejection.
Organ transplants, a viable treatment option for many patients
with end-stage cardiac or renal disease, have been done with
mixed success for over 50 years. Immune rejection presents a
particular problem when the goal is to provide such patients
with functional organs from a living or recently deceased donor.
Essentially, there are four major varieties of grafts:
1. Autografts are tissue grafts transplanted from one body
site to another in the same person.
2. Isografts are grafts donated to a patient by a genetically
identical individual, the only example being identical twins.
3. Allografts are grafts transplanted from individuals that
are not genetically identical but belong to the same species.
4. Xenografts are grafts taken from another animal species,
such as transplanting a baboon heart into a human being.
Transplant success depends on the similarity of the tissues
because T cells, NK cells, macrophages, and antibodies act vigorously to destroy any foreign tissue in the body. Autografts and
isografts are the ideal donor tissues. Given an adequate blood
supply and no infection, they are always successful because the
MHC proteins are identical.
Successful xenografts from genetically engineered animals
are still just a promise on the horizon. Consequently, the problematic graft type, and also the type most frequently used, is the
allograft. The organ is usually obtained from a living human
donor (in the case of kidney, liver, bone marrow) or harvested
from a human donor who has just died (heart or lung).
Before an allograft is attempted, the ABO and other blood
group antigens of donor and recipient must be determined, because these antigens are also present on most body cells. Next,
recipient and donor tissues are typed to determine their MHC
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 793
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Adaptive defenses
Cytotoxic
T cell (TC)
Cellular immunity
1 TC binds tightly to
the target cell when it
identifies foreign antigen
on MHC I proteins.
2 TC releases perforin and
granzyme molecules from
its granules by exocytosis.
Granule
Perforin
TC cell
membrane
Target
cell
membrane
Target
cell
793
3 Perforin molecules
insert into the target
cell membrane,
polymerize, and form
transmembrane pores
(cylindrical holes)
similar to those
produced by
complement
activation.
4 Granzymes enter
the target cell via the
pores. Once inside,
these proteases
degrade cellular
contents, stimulating
apoptosis.
Perforin
pore
Granzymes
5 The TC detaches and
searches for another prey.
(a) A mechanism of target cell killing by T C cells.
Cytotoxic
T cell
21
Cancer cell
(b) Scanning electron micrograph of a
TC cell killing a cancer cell (2100ⴛ).
Figure 21.20 Cytotoxic T cells attack infected and cancerous cells.
antigen match. MHC variation among human tissues is
tremendous, so matching for all MHC antigens is impossible. In
general, however, the closer the match the less likely is rejection.
Following surgery the patient is treated with immunosuppressive therapy. It involves drugs of the following categories:
(1) corticosteroid drugs to suppress inflammation; (2) antipro-
liferative drugs, and (3) immunosuppressant drugs. Many of
these drugs kill rapidly dividing cells (such as activated lymphocytes), and all of them have severe side effects.
The major problem with immunosuppressive therapy is that
the patient’s suppressed immune system cannot protect the
body against other foreign agents. As a result, overwhelming
000200010270575674_R1_CH21_p0766-0803.qxd
794
11/2/2011 02:45 PM Page 794
UN I T 4 Maintenance of the Body
Cell-mediated
immunity
Humoral
immunity
Antigen (Ag) intruder
Inhibits
Inhibits
Triggers
Innate defenses
Adaptive defenses
Surface
barriers
Internal
defenses
Free Ags
may directly
activate B cell
Ag-infected
body cell engulfed
by dendritic cell
Antigenactivated
B cells
Activates
Activates
Naive
CD8
T cells
Activated to clone
and give rise to
21
Memory
cytotoxic
T cells
Co-stimulate and release cytokines
Ag-presenting cell
(APC) presents
self-Ag complex
Naive
CD4
T cells
Induce
co-stimulation
Activated to clone
and give rise to
Memory
helper
T cells
Present Ag to activated helper T cells
Becomes
Clone and
give rise to
Memory
B cells
Plasma cells
(effector B cells)
Secrete
Activated
cytotoxic
T cells
Activated
helper
T cells
Cytokines stimulate
Antibodies (Igs)
Together the nonspecific killers
and cytotoxic T cells mount a
physical attack on the Ag
Nonspecific killers
(macrophages and
NK cells of innate
immunity)
Figure 21.21 Simplified summary of the primary immune response. Co-stimulation
usually requires direct cell-cell interactions; cytokines enhance these and many other events.
Although complement, NK cells, and phagocytes are innate defenses, they are enlisted in the
fight by cytokines. (For simplicity, only B cell receptors are illustrated.)
Circulating lgs along with complement
mount a chemical attack on the Ag
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 795
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
TABLE 21.5
795
Cells and Molecules of the Adaptive Immune Response
ELEMENT
FUNCTION IN IMMUNE RESPONSE
Cells
B cell
Lymphocyte that matures in bone marrow. Induced to replicate by antigen binding, usually followed by helper T cell
interactions in lymphoid tissues. Its progeny (clone members) form memory cells and plasma cells.
Plasma cell
Antibody-producing “machine”; produces huge numbers of antibodies (immunoglobulins) with the same antigen
specificity. An effector B cell.
Helper T cell (TH)
An effector CD4 T cell central to both humoral and cellular immunity. After binding with a specific antigen presented
by an APC, it stimulates production of cytotoxic T cells and plasma cells to help fight invader, activates macrophages,
and acts both directly and indirectly by releasing cytokines.
Cytotoxic T cell (TC)
An effector CD8 cell. Activated by antigen presented by an APC, often with helper T cell involvement. Its specialty is
killing virus-invaded body cells and cancer cells; also involved in rejection of foreign tissue grafts.
Regulatory T cell
(TReg)
Slows or stops activity of immune system. Important in controlling autoimmune diseases; several different populations probably exist.
Memory cell
Descendant of activated B cell or any class of T cell; generated during initial immune response (primary response).
May exist in body for years after, enabling it to respond quickly and efficiently to subsequent infections or meetings
with same antigen.
Antigen-presenting
cell (APC)
Any of several cell types (dendritic cell, macrophage, B cell) that engulfs and digests antigens that it encounters, presenting parts of them on its plasma membrane (bound to an MHC protein) for recognition by T cells bearing receptors
for same antigen. This function, antigen presentation, is essential for normal cell-mediated responses. Macrophages
and dendritic cells also release chemicals (cytokines) that activate many other immune cells.
Molecules
Antigen
Substance capable of provoking an immune response. Typically a large complex molecule (e.g., protein or modified
protein) not normally present in the body.
Antibody
(immunoglobulin)
Protein produced by B cell or by plasma cell. Antibodies produced by plasma cells are released into body fluids
(blood, lymph, saliva, mucus, etc.), where they attach to antigens, causing complement fixation, neutralization, precipitation, or agglutination, which “mark” the antigens for destruction by phagocytes or complement.
Perforins, granzymes
Released by TC cells. Perforins create large pores in the target cell’s membrane, allowing entry of apoptosis-inducing
granzymes.
Complement
Group of bloodborne proteins activated after binding to antibody-covered antigens or certain molecules on the surface of microorganisms; enhances inflammatory response and causes lysis of some microorganisms.
Cytokines
Small proteins that act as chemical messengers between various parts of the immune system. See Table 21.4.
21
bacterial and viral infection remains the most frequent cause of
death in transplant patients. The key to successful graft survival
is to provide enough immunosuppression to prevent graft rejection but not enough to be toxic, and to use antibiotics to keep
infection under control. Even with the best conditions, by ten
years after receiving a transplant, roughly 50% of patients have
rejected the donor organ.
In rare cases, transplant patients have naturally achieved a
state of immune tolerance and have been able to “ditch the
drugs.” Finding a way to induce tolerance is the goal of many research projects. One approach is to create a chimeric immune
system (chimer ⫽ monster) by temporarily suppressing the recipient’s bone marrow and then dousing it with bone marrow
from the same donor as the new organ in the hope that this
combined immune system will treat the transplanted organ as
self. Another approach tries to harness the body’s own toleranceinducing cells, the regulatory T cells, to suppress only those
immune reactions that lead to transplant rejection.
C H E C K Y O U R U N D E R S TA N D I N G
19. Which type of T cell is the most important in both cellmediated and humoral immunity? Why?
20. Describe the killing mechanism of cytotoxic T cells that involves perforins.
21. Which proteins must be carefully matched before an organ
transplant?
For answers, see Appendix G.
Homeostatic Imbalances
of Immunity
䉴 Give examples of immune deficiency diseases and of hypersensitivity states.
䉴 Cite factors involved in autoimmune disease.
000200010270575674_R1_CH21_p0766-0803.qxd
796
11/2/2011 02:45 PM Page 796
UN I T 4 Maintenance of the Body
Certain circumstances can cause the immune system to become
depressed, to fail, or to act in a way that damages the body. Most
such problems can be classified as immunodeficiencies, autoimmune diseases, or hypersensitivities.
Immunodeficiencies
21
Any congenital or acquired condition that causes immune cells,
phagocytes, or complement to behave abnormally is called an
immunodeficiency.
The most devastating congenital conditions are a group of related disorders called severe combined immunodeficiency
(SCID) syndromes, which result from various genetic defects
that produce a marked deficit of B and T cells. One SCID defect
causes abnormalities in a subunit common to the receptors for
several interleukins. Another results in a defective adenosine
deaminase (ADA) enzyme. In the absence of normal ADA,
metabolites that are lethal to T cells accumulate in the body.
Children afflicted with SCID have little or no protection
against disease-causing organisms of any type. Interventions
must begin in the first months of life because minor infections
easily shrugged off by most children cause SCID victims to become deathly ill and wasted. Untreated, this condition is fatal,
but successful transplants of matched donor hematopoietic
stem cells dramatically improve survival rates. Recent genetic
engineering techniques using viruses as vectors to transfer corrected genes to the victim’s own hematopoietic stem cells have
shown promise.
There are various acquired immunodeficiencies. For example,
Hodgkin’s disease, a cancer of the B cells, can lead to immunodeficiency by depressing lymph node cells. Immunosuppressive
drugs used in transplantation and certain drugs used to treat
cancer also suppress the immune system. But the most devastating of the acquired immunodeficiencies is acquired immune
deficiency syndrome (AIDS), which cripples the immune system by interfering with the activity of helper T cells.
First identified in the United States in 1981 among homosexual men and intravenous drug users, AIDS is characterized by
severe weight loss, night sweats, swollen lymph nodes, and increasingly frequent opportunistic infections, including a rare
type of pneumonia called pneumocystis pneumonia, and the
bizarre malignancy Kaposi’s sarcoma, a cancer of the blood vessels evidenced by purple skin lesions. Some AIDS victims develop severe dementia. The course of AIDS is often grim, finally
ending in complete debilitation and death from cancer or overwhelming infection.
AIDS is caused by a virus transmitted in body secretions—
especially blood, semen, and vaginal secretions. The virus commonly enters the body via blood transfusions or bloodcontaminated needles and during sexual intercourse. It is also
present in saliva and tears, and there are documented cases of
transmission by oral sex. Early in the epidemic, hemophiliacs
were also at particular risk because the blood factors they need
were isolated from pooled blood donations. Manufacturers began taking measures to kill the virus in 1984 and new genetically
engineered factors became available, but an estimated 60% of
the hemophiliacs in the U.S. were already infected.
The virus, HIV (human immunodeficiency virus), destroys
TH cells, depressing cell-mediated immunity. Although B cells
and TC cells initially mount a vigorous response to viral exposure, in time a profound deficit of B cell and cytotoxic T cell function develops. The whole immune system is turned topsy-turvy.
The virus multiplies steadily in the lymph nodes throughout
most of the asymptomatic period, which averages ten years in
the absence of treatment. Symptoms appear when the lymph
nodes can no longer contain the virus and the immune system
collapses. The virus also invades the brain (which accounts for
the dementia of some AIDS patients).
The infectious specificity of HIV reflects the fact that
CD4 proteins provide the avenue of attack. Researchers have
identified an HIV coat glycoprotein complex (gp120/gp41)
that fits into the CD4 receptor like a plug fits into a socket.
However, HIV also needs a second receptor (e.g., CXCR4) on
the target cell. Once all these proteins have connected, gp41
fuses the virus to the target cell. Once inside, HIV “sets up
housekeeping,” using the viral enzyme reverse transcriptase to
produce DNA from the information encoded in its (viral)
RNA. This DNA copy, now called a provirus, then inserts itself
into the target cell’s DNA and directs the cell to crank out new
copies of viral RNA and proteins so that the virus can multiply
and infect other cells.
Although TH cells are the main HIV targets, other body cells
displaying CD4 proteins (macrophages, monocytes, and dendritic cells) are also at risk. The HIV reverse transcriptase enzyme is not very accurate and produces errors rather frequently,
causing HIV’s relatively high mutation rate and its changing resistance to drugs.
The years since 1981 have witnessed a global AIDS epidemic.
By the end of 2007, 33 million people had died of AIDS since it
was first identified, and about 33 million people were living
with HIV worldwide, almost 90% of them in the developing
countries of Asia and sub-Saharan Africa. Half of the victims
are women, a case distribution indicating that in the most heavily
hit countries, most HIV transmission occurs via heterosexual
contacts. The virus can also be transmitted from an infected
mother to her fetus.
The estimated number of Americans infected with HIV is
now over 1 million. Of these, a quarter don’t yet know that
they are infected, either because anti-HIV antibodies are not
yet detectable in the blood (this may take as long as six months
after infection), or because (for one reason or another) they
have not yet been tested. The “face of AIDS” is changing too.
Homosexual men still account for the bulk of cases transmitted by sexual contact in the U.S., but more and more heterosexuals are contracting this disease. Particularly disturbing is
the number of diagnosed cases among teenagers and young
adults, with AIDS now the sixth leading killer of all Americans
ages 25 to 44.
No cure for AIDS has yet been found. Over 40 clinical trials
of HIV vaccines are under way around the world. Disappointingly, several large trials testing the effectiveness of vaccines have
failed to show any effect in blocking HIV infection, and it is unlikely that an approved vaccine will be available soon.
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 797
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Fortunately, a number of antiviral drugs are available, and
these fall into three broad classes. Reverse transcriptase inhibitors,
such as AZT and ddC, were early on the scene, followed by
protease inhibitors (saquinavir, ritonavir, and others). These first
two classes of drugs inhibit important viral enzymes after the
virus has gained entry into the target cell. New to the scene are
fusion inhibitors (such as enfuvirtide) that block gp41, preventing the virus from entering the cell in the first place. Combination therapy using three drugs at once delivers a one-two punch
to the virus. It postpones drug resistance and causes the viral
load (amount of HIV virus per milliliter of blood) to plummet
while boosting the number of TH cells.
Sadly, even combination drug therapies fail as the virus
becomes resistant. New hope comes from a class of drugs now
being developed that blocks integrase, the viral enzyme, responsible for integration of the HIV provirus into the target cell’s
DNA. However, drug research is slow and laborious and the
clock is ticking.
Autoimmune Diseases
Occasionally the immune system loses its ability to distinguish
friend (self) from foe (foreign antigens). When this happens,
the artillery of the immune system, like friendly fire, turns
against itself. The body produces antibodies (autoantibodies)
and cytotoxic T cells that destroy its own tissues. This puzzling
phenomenon is called autoimmunity. If a disease state results,
it is referred to as autoimmune disease.
Some 5% of adults in North America—two-thirds of them
women—are afflicted with autoimmune disease. Most common are
■
■
■
■
■
■
■
Multiple sclerosis, which destroys the myelin of the white
matter of the brain and spinal cord (see p. 405)
Myasthenia gravis, which impairs communication between
nerves and skeletal muscles (see p. 285)
Graves’ disease, which prompts the thyroid gland to produce
excessive amounts of thyroxine (see p. 611)
Type 1 (insulin-dependent) diabetes mellitus, which destroys
pancreatic beta cells, resulting in a deficit of insulin and inability to use carbohydrates (see p. 622)
Systemic lupus erythematosus (SLE), a systemic disease that
particularly affects the kidneys, heart, lungs, and skin (see
Related Clinical Terms)
Glomerulonephritis, a severe impairment of renal function
Rheumatoid arthritis, which systematically destroys joints
(see pp. 270–271)
The most widely used treatments of autoimmune diseases
suppress the entire immune system, relying, for example, on
anti-inflammatory drugs such as corticosteroids. Newer treatments seek to target specific aspects of the immune response.
For example, antibodies against TNF-␣ have provided dramatic
results in the treatment of rheumatoid arthritis. Thalidomide,
used in the 1950s to alleviate morning sickness in pregnancy
until it was found to cause tragic birth defects, has been given a
second chance in treating autoimmune disease because it blocks
TNF production. Another therapeutic approach uses antibodies
797
against cell adhesion molecules, preventing lymphocytes from
exiting blood vessels into target areas. This approach shows
promise in helping victims of a variety of autoimmune disorders, and has been used to treat multiple sclerosis. Another
novel treatment for multiple sclerosis involves injecting a DNA
vaccine that induces tolerance to the myelin antigen targeted by
the autoimmune reaction.
How do autoimmune diseases arise? As you recall, lymphocytes undergo an extensive education in the bone marrow and
thymus that weeds out self-reactive cells. This weeding is thorough, but not too thorough, since there are pathogens that
look somewhat like self. Weakly self-reactive lymphocytes that
can detect these kinds of pathogens are allowed into the periphery, where they may cause autoimmune disease if they become activated.
Recall that activation of a T cell requires a co-stimulatory signal on an APC (see p. 789), and that these co-stimulatory signals
are only present if the APC has received “danger” signals alerting
it to the presence of damage or invaders. This is an important
safety check that generally keeps both humoral and cellular immunity under control. In addition, regulatory T (TReg) cells also
inhibit autoimmune reactions.
Normally, these mechanisms are sufficient, but sometimes
self-reactive lymphocytes slip out of control. It appears that one
of the following events may trigger this:
1. Foreign antigens resemble self-antigens. If the determinants on a self-antigen resemble those on a foreign antigen, antibodies made against the foreign antigen can
cross-react with the self-antigen. For instance, antibodies
produced during a streptococcal infection react with heart
antigens, causing lasting damage to the heart muscle and
valves, as well as to joints and kidneys. This age-old disease
is called rheumatic fever.
2. New self-antigens appear. Self-proteins not previously exposed to the immune system may appear in the circulation. They may be generated by (1) gene mutations that
cause new proteins to appear at the external cell surface,
(2) changes in the structure of self-antigens by hapten attachment or as a result of infectious damage, or (3) release
by trauma of novel self-antigens normally hidden behind
barriers such as the blood-brain barrier. These newly generated proteins then become immune system targets.
Hypersensitivities
At first, the immune response was thought to be purely protective. However, it was not long before its dangerous potentials
were discovered. Hypersensitivities result when the immune
system causes tissue damage as it fights off a perceived threat
(such as pollen or animal dander) that would otherwise be
harmless to the body. People rarely die of hypersensitivities.
They are just miserable with them.
The different types of hypersensitivity reactions are distinguished by (1) their time course, and (2) whether antibodies or
T cells are involved. Hypersensitivities mediated by antibodies
are the immediate and subacute hypersensitivities. T cells cause
delayed hypersensitivity.
21
000200010270575674_R1_CH21_p0766-0803.qxd
798
11/2/2011 02:45 PM Page 798
UN I T 4 Maintenance of the Body
Adaptive defenses
Immediate Hypersensitivities
Humoral immunity
Sensitization stage
1 Antigen (allergen)
invades body.
2 Plasma cells produce
large amounts of class
IgE antibodies against
allergen.
Mast cell with
fixed IgE
antibodies
IgE
3 IgE antibodies
attach to mast cells in
body tissues (and to
circulating basophils).
Granules
containing
histamine
Subsequent (secondary)
responses
4 More of same
antigen invades body.
Antigen
5 Antigen combines
with IgE attached
to mast cells (and
basophils), which triggers
degranulation and release
of histamine (and other
chemicals).
21
Mast cell granules
release contents
after antigen binds
with IgE antibodies
Histamine
6 Histamine causes blood vessels to dilate and become leaky,
which promotes edema; stimulates secretion of large amounts
of mucus; and causes smooth muscles to contract. (If respiratory
system is site of antigen entry, asthma may ensue.)
Outpouring of fluid
from capillaries
Release of mucus
Constriction of small
respiratory passages
(bronchioles)
Figure 21.22 Mechanism of an acute allergic (immediate
hypersensitivity) response.
The immediate hypersensitivities, also called acute or type I hypersensitivities, are simply what most of us would call allergies
(allo ⫽ altered; erg ⫽ reaction). An allergen is an antigen that
causes an allergic reaction. Allergic reactions begin within seconds after contact with the allergen and last about half an hour.
The initial meeting with an allergen produces no symptoms
but it sensitizes the person. APCs digest the allergen and present
its fragments to TH cells as usual. In susceptible individuals, an
abnormally large number of these TH cells differentiate into
IL-4-secreting TH2 cells. IL-4 stimulates B cells to mature into
IgE-secreting plasma cells, which spew out huge amounts of antibody specific for the allergen. When the IgE molecules attach
to mast cells and basophils, sensitization is complete.
An allergic reaction is triggered by later encounters with the
same allergen, which promptly binds and cross-links the IgE antibodies on the surfaces of the mast cells and basophils. This
event induces an enzymatic cascade that causes the mast cells
and basophils to degranulate, releasing a flood of histamine and
other inflammatory chemicals that together induce the inflammatory response typical of allergy (Figure 21.22).
Allergic reactions may be local or systemic. Mast cells are
abundant in connective tissues of the skin and beneath the mucosa of respiratory passages and the gastrointestinal tract, and
these areas are common sites of local allergic reactions. Histamine causes blood vessels to become dilated and leaky, and is
largely to blame for the best recognized symptoms of allergy:
runny nose, itching reddened skin (hives), and watery eyes.
When the allergen is inhaled, symptoms of asthma appear because smooth muscle in the walls of the bronchioles contracts,
constricting those small passages and restricting air flow. When
the allergen is ingested in food or via drugs, gastrointestinal
discomfort (cramping, vomiting, or diarrhea) occurs. Over-thecounter antiallergy drugs contain antihistamines that counteract these effects.
The bodywide or systemic response known as anaphylactic
shock is fairly rare. It typically occurs when the allergen directly
enters the blood and circulates rapidly through the body, as
might happen with certain bee stings or spider bites. It may also
follow injection of a foreign substance (such as penicillin or
other drugs which act as haptens).
The mechanism of anaphylactic shock is essentially the same
as that of local responses, but when mast cells and basophils are
enlisted throughout the entire body, the outcome is life threatening. The bronchioles constrict (and the tongue may swell),
making it difficult to breathe, and the sudden vasodilation and
fluid loss from the bloodstream may cause circulatory collapse
(hypotensive shock) and death within minutes. Epinephrine is
the drug of choice to reverse these histamine-mediated effects.
Subacute Hypersensitivities
Like the immediate types, subacute hypersensitivities are
caused by antibodies (IgG and IgM rather than IgE) and can be
transferred via blood plasma or serum. However, their onset is
slower (1–3 hours after antigen exposure) and the duration of
the reaction is longer (10–15 hours).
000200010270575674_R1_CH21_p0766-0803.qxd
11/2/2011 02:45 PM Page 799
Chapter 21 The Immune System: Innate and Adaptive Body Defenses
Cytotoxic (type II) reactions occur when antibodies bind to
antigens on specific body cells and subsequently stimulate
phagocytosis and complement-mediated lysis of the cellular
antigens. Type II hypersensitivity may occur after a patient has
received a transfusion of mismatched blood and the foreign red
blood cells are lysed by complement.
Immune-complex (type III) hypersensitivity results when
antigens are widely distributed through the body or blood and
the insoluble antigen-antibody complexes formed cannot be
cleared from a particular area. (This may reflect a persistent
infection or a situation in which huge amounts of antigenantibody complexes are formed.) An intense inflammatory
reaction occurs, complete with complement-mediated cell lysis
and cell killing by neutrophils that severely damages local tissues. One example of type III hypersensitivity is farmer’s lung
(induced by inhaling moldy hay). Additionally, many immunecomplex responses are involved in autoimmune disorders, such
as glomerulonephritis, systemic lupus erythematosus, and
rheumatoid arthritis.
Delayed Hypersensitivities
Delayed hypersensitivity (type IV) reactions are slower to
appear (1–3 days) than antibody-mediated hypersensitivity reactions. The mechanism is basically that of a cell-mediated immune
response, which depends on helper T cells. Inflammation and
tissue damage comes about through the action of cytokineactivated macrophages, and sometimes cytotoxic T cells.
The most familiar examples of delayed hypersensitivity reactions are those classified as allergic contact dermatitis which
follow skin contact with poison ivy, some metals (nickel in jewelry), and certain cosmetic and deodorant chemicals. These
agents act as haptens, and after diffusing through the skin and
attaching to self-proteins, they are perceived as foreign by the
immune system. The Mantoux and tine tests, two skin tests for
tuberculosis, depend on delayed hypersensitivity reactions.
When the tubercle antigens are introduced just under the skin,
a small hard lesion forms that persists for days if the person has
been sensitized to the antigen.
C H E C K Y O U R U N D E R S TA N D I N G
22. What makes HIV particularly hard for the immune system to
defeat?
23. What event triggers the release of histamine from mast cells
in an allergic response?
For answers, see Appendix G.
Developmental Aspects
of the Immune System
䉴 Describe changes in immunity that occur with aging.
䉴 Briefly describe the role of the nervous system in regulating
the immune response.
799
Stem cells of the immune system originate in the liver and
spleen during weeks 1–9 of embryonic development. Later the
bone marrow becomes the predominant source of stem cells,
and it persists in this role into adult life. In late fetal life and
shortly after birth, the young lymphocytes develop self-tolerance
and immunocompetence in their “programming organs” (thymus and bone marrow) and then populate the other lymphoid
tissues. When challenged by an antigen, the naive T and B cells
further differentiate into effector cells and memory cells.
The newborn’s immune system depends primarily on antibodies, and hence on TH2 lymphocytes. The TH1 system is educated and gets stronger as a result of encounters with
microbes—both harmful and harmless. If such “exercise” does
not occur, immune balance is upset and the TH2 system flourishes, causing the immune system to teeter toward allergies.
Unhappily, our desire to keep our children squeaky clean with
antibiotics that kill off both harmful and harmless bacteria may
derail normal immune development.
The ability of the immune system to recognize foreign substances is controlled by genes. However, the nervous system also
plays a role in the immune response, and studies of psychoneuroimmunology—a brain-twisting term coined to describe links
between the brain and the immune system—have begun to reveal some answers. For example, the immune response is definitely impaired in individuals who are depressed or under
severe stress, such as those mourning the death of a beloved
family member or friend.
Our immune system normally serves us very well until late in
life. Then its efficiency begins to wane, and its ability to fight infection declines. Old age is also accompanied by greater susceptibility to both immune deficiency and autoimmune diseases.
The greater incidence of cancer in the elderly is assumed to be an
example of the progressive failure of the immune system. We do
not know why the immune system begins to fail, but we do know
that the thymus begins to atrophy after puberty and the production of naive T and B cells declines with age, possibly because
progenitor cells reach the limits of their ability to further divide.
21
■ ■ ■
The adaptive immune system provides remarkable defenses
against disease. These amazingly diverse defenses are regulated
by cellular interactions and a flood of chemicals. T cells and antibodies make perfect partners. Antibodies respond swiftly to
toxins and molecules on the outer surfaces of foreign organisms, and T cells destroy foreign antigens hidden inside cells and
our own cells that have become mutinous (cancer cells). The innate immune system exhibits a different arsenal for body defense, an arsenal that is simpler perhaps and more easily
understood. The innate and adaptive defenses are tightly interlocked, each providing what the other cannot and amplifying
each other’s effects.